Literature DB >> 28150151

Structure-based assessment of disease-related mutations in human voltage-gated sodium channels.

Weiyun Huang1,2,3, Minhao Liu2, S Frank Yan4, Nieng Yan5,6,7.   

Abstract

Voltage-gated sodium (Nav) channels are essential for the rapid upstroke of action potentials and the propagation of electrical signals in nerves and muscles. Defects of Nav channels are associated with a variety of channelopathies. More than 1000 disease-related mutations have been identified in Nav channels, with Nav1.1 and Nav1.5 each harboring more than 400 mutations. Nav channels represent major targets for a wide array of neurotoxins and drugs. Atomic structures of Nav channels are required to understand their function and disease mechanisms. The recently determined atomic structure of the rabbit voltage-gated calcium (Cav) channel Cav1.1 provides a template for homology-based structural modeling of the evolutionarily related Nav channels. In this Resource article, we summarized all the reported disease-related mutations in human Nav channels, generated a homologous model of human Nav1.7, and structurally mapped disease-associated mutations. Before the determination of structures of human Nav channels, the analysis presented here serves as the base framework for mechanistic investigation of Nav channelopathies and for potential structure-based drug discovery.

Entities:  

Keywords:  Nav channels; Nav1.7; channelopathy; pain; structure modeling

Mesh:

Substances:

Year:  2017        PMID: 28150151      PMCID: PMC5445024          DOI: 10.1007/s13238-017-0372-z

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


INTRODUCTION

Voltage-gated sodium (Nav) channels are essential for the rapid depolarization phase of action potential and play a key role in the electrical signaling in most excitable cells. Structurally, Nav channels are composed of one α subunit and one or more β subunits. The α subunit contains two functionally distinct structural entities, namely, the voltage-sensing domains (VSDs) and the ion-conducting pore domain (Catterall, 2012b, 2014). The β subunits, which bind to α subunit covalently or non-covalently, modulate membrane trafficking, voltage dependence, and channel gating kinetics (Catterall, 2012b, 2014). In mammals, Nav channels have nine known α members distributed in different excitable tissues. Specifically, Nav1.1, Nav1.2, Nav1.3, and Nav1.6 are the primary sodium channels in central nervous system (CNS), Nav1.4 is primarily expressed in skeletal muscle, Nav1.5 is mainly expressed in heart, and Nav1.7, Nav1.8, and Nav1.9 are mainly distributed in peripheral nervous system (Plummer and Meisler, 1999; Goldin, 2001; Catterall et al., 2005). All α subunits share nearly identical structure topology—a canonical voltage-gated ion channel fold with four homologous repeats, each containing six transmembrane segments S1–S6. Specifically, S5–S6 segments form the pore domain that conducts selective sodium filtering, while S1–S4 segments constitute the voltage-sensing domain that controls voltage-dependent gating (Catterall, 2000). The voltage sensors in the VSDs are featured by a number of positively charged amino acids (arginine or lysine) located at every third position in the S4 segment. Upon membrane depolarization, movements of these charged residues in the S4 segment are coupled to the opening of the pore domain and the subsequent influx of sodium ions across cell membrane. The pore domain is structurally organized with a four-fold pseudo-symmetry. The pore (P) loops, which are supported by the P1 helix (corresponding to the P helix in potassium channel) and P2 helix between S5 and S6 segments in each repeat, constitute the selectivity filter (SF) (Corry and Thomas, 2012). Four amino acid residues (aspartate, glutamate, lysine, and alanine, DEKA, in repeats I, II, III, and IV, respectively) in the P loops are crucial for sodium selectivity. Mutating these residues to glutamates confers calcium selectivity, suggesting that the side chains of these amino acids are likely to interact directly with the sodium ions to determine ion selectivity (Heinemann et al., 1992; Sun et al., 1997). Nav channels inactivate rapidly. A cluster of hydrophobic amino acids (isoleucine, phenylalanine, methionine, and threonine), namely the IFMT motif, located in the cytosolic regions of domain III and domain IV, are required for rapid inactivation. This is demonstrated by the fact that rapid inactivation could be achieved by titrating small peptides containing the IFMT motif (Vassilev et al., 1988; West et al., 1992). Sodium channelopathies are a group of diseases caused by defective Nav channels, either, in most cases, of congenital nature or acquired nature (Tables 1, 2, 3, 4, 5, 6, 7, 8, 9, 10) (George, 2005; Catterall, 2012a; Kim, 2014). For example, Nav1.1 is primarily expressed in the soma of neuronal cells in the CNS, and mutations of Nav1.1 cause GEFS+2 (generalized epilepsy with febrile seizures plus 2) (Catterall et al., 2010). Moreover, mutations of Nav1.1 are also the main causes of EIEE6 (epileptic encephalopathy, early infantile, 6) and ICEGTC (intractable childhood epilepsy with generalized tonic-clonic seizures) (Escayg and Goldin, 2010). Nav1.5 is the major sodium channel expressed in heart. Nav1.5 mutations may lead to various cardiac diseases such as LQT3 (long QT syndrome 3), BRGDA1 (Brugada syndrome 1), and SSS1 (sick sinus syndrome 1) (Olson et al., 2005; Song and Shou, 2012; Veerman et al., 2015). Nav1.7 is preferentially expressed in the sympathetic neurons, olfactory epithelium, and dorsal root ganglion sensory neurons, and plays a cardinal role in pain transmission (Djouhri et al., 2003; Dib-Hajj et al., 2013). Gain-of-function mutations of Nav1.7 are implicated in two distinct paroxysmal pain syndromes—IEM (primary erythermalgia) and PEPD (paroxysmal extreme pain disorder), while loss-of-function mutations of Nav1.7 inflict people with CIP (indifference to pain, congenital, autosomal recessive) (Lampert et al., 2010; Dib-Hajj et al., 2013). In all, Nav channel mutations play a central role in the pathophysiology of sodium channelopathies. Pharmacologic modulation of Nav channels may thereby represent a viable therapeutic approach for the treatment of many neurological disorders such as epilepsy, arrhythmia, and pain.
Table 1

Structural mapping of disease-related mutations identified in human Nav1.7

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.7Q10RIEMN-terminusQ10
hNav1.7I62VFEBN-terminusI62
hNav1.7I136VIEMDI S1I136
hNav1.7P149QFEBDI S1-S2P149
hNav1.7R185HPEPDDI S3R185
hNav1.7R185HSFNDI S3R185
hNav1.7S211PIEMDI S3-S4S211
hNav1.7F216SIEMDI S4F216
hNav1.7I228MDSDI S4I228
hNav1.7I228MSFNDI S4I228
hNav1.7I234TIEMDI S5I234
hNav1.7S241TIEMDI S5S241
hNav1.7L245VIEMDI S5L245
hNav1.7N395KIEMDI S6N395
hNav1.7V400MIEMDI S6V400
hNav1.7E406KIEMDI S6E406
hNav1.7S490NFEBDI - DIIS490
hNav1.7E519KDSDI - DIIE519
hNav1.7P610TIEMDI - DIIP610
hNav1.7G616RIEMDI - DIIG616
hNav1.7D623NSFNDI - DIID623
hNav1.7N641YFEBDI - DIIN641
hNav1.7K666RFEBDI - DIIK666
hNav1.7K666RDSDI - DIIK666
hNav1.7I695MDSDI - DIII695
hNav1.7C710YDSDI - DIIC710
hNav1.7I731KSFNDI - DIII731
hNav1.7I750VSFNDII S1I750
hNav1.7I750VDSDII S1I750
hNav1.7I750VFEBDII S1I750
hNav1.7L834RIEMDII S4L834
hNav1.7I859TIEMDII S5I859
hNav1.7G867DIEMDII S5G867
hNav1.7L869FIEMDII S5L869
hNav1.7L869HIEMDII S5L869
hNav1.7A874PIEMDII S5A874
hNav1.7V883GIEMDII S5V883
hNav1.7Q886EIEMDII S5Q886
hNav1.7R907QCIPDII S5-S6R907
hNav1.7M943LSFNDII S5-S6M943
hNav1.7V1002LSFNDII - DIIIV1002
hNav1.7R1007CPEPDDII - DIIIR1007
hNav1.7L1134FDSDII - DIIIL1134
hNav1.7E1171QDSDII - DIIIE1171
hNav1.7A1247ECIPDIII S2A1247
hNav1.7L1278VDSDIII S3-S4L1278
hNav1.7V1309DPEPDDIII S4-S5V1309
hNav1.7V1309FPEPDDIII S4-S5V1309
hNav1.7V1310FPEPDDIII S4-S5V1310
hNav1.7P1319LIEMDIII S4-S5P1319
hNav1.7F1460VIEMDIII S6F1460
hNav1.7I1472TPEPDDIII - DIVI1472
hNav1.7F1473VPEPDDIII - DIVF1473
hNav1.7T1475IPEPDDIII - DIVT1475
hNav1.7M1543ISFNDIV S2M1543
hNav1.7G1618RPEPDDIV S4G1618
hNav1.7L1623PPEPDDIV S4L1623
hNav1.7M1638KPEPDDIV S5M1638
hNav1.7A1643EPEPDDIV S5A1643
hNav1.7A1643EIEMDIV S5A1643
hNav1.7A1643GIEMDIV S5A1643
hNav1.7A1643TIEMDIV S5A1643
hNav1.7W1786RCIPC-terminusW1786

IEM: Primary erythermalgia; PEPD: Paroxysmal extreme pain disorder; CIP: Indifference to pain, congenital, autosomal recessive; DS: Dravet syndrome; SFN: Small fiber neuropathy; FEB: Febrile seizures

Table 2

Structural mapping of disease-related mutations identified in human Nav1.1

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.1R27TGEFS+2N-terminusQ25
hNav1.1S74PGEFS+2N-terminusS72
hNav1.1D188VGEFS+2DI S3D186
hNav1.1F218LGEFS+2DI S4F216
hNav1.1T254IGEFS+2DI S5T252
hNav1.1S291GGEFS+2DI S5-S6S279
hNav1.1R377QGEFS+2DI S5-S6R356
hNav1.1Y388HGEFS+2DI S5-S6Y367
hNav1.1Y790CGEFS+2DII S1-S2H766
hNav1.1R859CGEFS+2DII S4R835
hNav1.1R859HGEFS+2DII S4R835
hNav1.1T875MGEFS+2DII S4-S5T851
hNav1.1I899TGEFS+2DII S5I875
hNav1.1N935HGEFS+2DII S5-S6N911
hNav1.1R946HGEFS+2DII S5-S6R922
hNav1.1M960TGEFS+2DII S5-S6M936
hNav1.1M973VGEFS+2DII S6M949
hNav1.1M976IGEFS+2DII S6M952
hNav1.1I978MGEFS+2DII S6I954
hNav1.1W1204RGEFS+2DII - DIIIW1178
hNav1.1W1204SGEFS+2DII - DIIIW1178
hNav1.1L1230FGEFS+2DIII S1L1204
hNav1.1K1249NGEFS+2DIII S2K1223
hNav1.1T1250MGEFS+2DIII S2I1224
hNav1.1K1270TGEFS+2DIII S2K1244
hNav1.1L1309FGEFS+2DIII S3-S4L1283
hNav1.1V1353LGEFS+2DIII S5V1327
hNav1.1V1366IGEFS+2DIII S5V1340
hNav1.1N1414DGEFS+2DIII S5-S6N1388
hNav1.1V1428AGEFS+2DIII S5-S6V1402
hNav1.1R1596HGEFS+2DIV S2-S3R1570
hNav1.1R1648HGEFS+2DIV S4R1622
hNav1.1I1656MGEFS+2DIV S5I1630
hNav1.1R1657CGEFS+2DIV S5R1631
hNav1.1A1685VGEFS+2DIV S5A1659
hNav1.1F1687SGEFS+2DIV S5F1661
hNav1.1P1739LGEFS+2DIV S5-S6P1713
hNav1.1D1742GGEFS+2DIV S5-S6D1716
hNav1.1F1765LGEFS+2DIV S6Y1739
hNav1.1E1795KGEFS+2C-terminusE1769
hNav1.1M1852TGEFS+2C-terminusM1826
hNav1.1V1857LGEFS+2C-terminusV1831
hNav1.1D1866YGEFS+2C-terminusD1840
hNav1.1I1867TGEFS+2C-terminusI1841
hNav1.1G58VEIEE6N-terminusG56
hNav1.1L61FEIEE6N-terminusL59
hNav1.1F63LEIEE6N-terminusF61
hNav1.1I68TEIEE6N-terminusI66
hNav1.1E78DEIEE6N-terminusE76
hNav1.1D79HEIEE6N-terminusD77
hNav1.1D79NEIEE6N-terminusD77
hNav1.1Y84CEIEE6N-terminusY82
hNav1.1F90SEIEE6N-terminusF88
hNav1.1I91TEIEE6N-terminusI89
hNav1.1A98PEIEE6N-terminusT96
hNav1.1R101QEIEE6N-terminusR99
hNav1.1R101WEIEE6N-terminusR99
hNav1.1S103GEIEE6N-terminusN101
hNav1.1T105IEIEE6N-terminusT103
hNav1.1L108REIEE6N-terminusL106
hNav1.1T112IEIEE6N-terminusS110
hNav1.1R118SEIEE6N-terminusR116
hNav1.1I124NEIEE6N-terminusI122
hNav1.1H127DEIEE6N-terminusH125
hNav1.1T162PEIEE6DI S2T160
hNav1.1I171KEIEE6DI S2V169
hNav1.1I171REIEE6DI S2V169
hNav1.1A175TEIEE6DI S2-23A173
hNav1.1A175VEIEE6DI S2-S3A173
hNav1.1G177EEIEE6DI S2-S3G175
hNav1.1C179REIEE6DI S2-S3C177
hNav1.1W190REIEE6DI S3W188
hNav1.1N191KEIEE6DI S3N189
hNav1.1N191YEIEE6DI S3N189
hNav1.1D194GEIEE6DI S3D192
hNav1.1D194NEIEE6DI S3D192
hNav1.1T199REIEE6DI S3V197
hNav1.1T217KEIEE6DI S3-S4T215
hNav1.1A223EEIEE6DI S4A221
hNav1.1T226MEIEE6DI S4T224
hNav1.1T226REIEE6DI S4T224
hNav1.1I227SEIEE6DI S4I225
hNav1.1I227TEIEE6DI S4I225
hNav1.1G232SEIEE6DI S4-S5G230
hNav1.1L233REIEE6DI S5L231
hNav1.1A239TEIEE6DI S5A237
hNav1.1A239VEIEE6DI S5A237
hNav1.1S243YEIEE6DI S5S241
hNav1.1I252NEIEE6DI S5I250
hNav1.1S259REIEE6DI S5S257
hNav1.1G265WEIEE6DI S5G263
hNav1.1C277REIEE6DI S5-S6C275
hNav1.1W280CEIEE6DI S5-S6N278
hNav1.1W280REIEE6DI S5-S6N278
hNav1.1P281AEIEE6DI S5-S6S279
hNav1.1P281LEIEE6DI S5-S6S279
hNav1.1P281SEIEE6DI S5-S6S279
hNav1.1E289VEIEE6DI S5-S6E287
hNav1.1T297IEIEE6DI S5-S6
hNav1.1R322IEIEE6DI S5-S6R301
hNav1.1S340FEIEE6DI S5-S6T319
hNav1.1A342VEIEE6DI S5-S6S321
hNav1.1G343DEIEE6DI S5-S6G322
hNav1.1C345REIEE6DI S5-S6C324
hNav1.1C351WEIEE6DI S5-S6C330
hNav1.1G355DEIEE6DI S5-S6G334
hNav1.1R356GEIEE6DI S5-S6R335
hNav1.1N357IEIEE6DI S5-S6N336
hNav1.1P358TEIEE6DI S5-S6P357
hNav1.1N359SEIEE6DI S5-S6D338
hNav1.1T363PEIEE6DI S5-S6T342
hNav1.1T363REIEE6DI S5-S6T342
hNav1.1D366EEIEE6DI S5-S6D345
hNav1.1L378QEIEE6DI S5-S6L357
hNav1.1M379REIEE6DI S5-S6M358
hNav1.1F383LEIEE6DI S5-S6Y362
hNav1.1W384REIEE6DI S5-S6M363
hNav1.1R393CEIEE6DI S5-S6R372
hNav1.1R393HEIEE6DI S5-S6R372
hNav1.1R393SEIEE6DI S5-S6R372
hNav1.1M400VEIEE6DI S5-S6M379
hNav1.1F403LEIEE6DI S6F383
hNav1.1F403VEIEE6DI S6F382
hNav1.1V406FEIEE6DI S6V385
hNav1.1L409WEIEE6DI S6L388
hNav1.1Y413NEIEE6DI S6Y392
hNav1.1Y426CEIEE6DI S6Y405
hNav1.1Y426NEIEE6DI S6Y405
hNav1.1S525FEIEE6DI - DIIS505
hNav1.1S626GEIEE6DI - DIIS606
hNav1.1D674GEIEE6DI - DIID651
hNav1.1N762DEIEE6DI - DIIY738
hNav1.1L783PEIEE6DII S1L759
hNav1.1M785TEIEE6DII S1-S2M761
hNav1.1T812IEIEE6DII S2A788
hNav1.1T812REIEE6DII S2A788
hNav1.1L842REIEE6DII S3L818
hNav1.1S843REIEE6DII S3S819
hNav1.1E846KEIEE6DII S3E822
hNav1.1R859CEIEE6DII S4R835
hNav1.1R862QEIEE6DII S4R838
hNav1.1R865GEIEE6DII S4R841
hNav1.1T875KEIEE6DII S4-S5T851
hNav1.1T875MEIEE6DII S4-S5T851
hNav1.1L876IEIEE6DII S5L852
hNav1.1L890PEIEE6DII S5L866
hNav1.1V896FEIEE6DII S5V872
hNav1.1V896LEIEE6DII S5V872
hNav1.1F902CEIEE6DII S5F878
hNav1.1C927FEIEE6DII S5-S6C903
hNav1.1R931CEIEE6DII S5-S6R907
hNav1.1W932CEIEE6DII S5-S6W908
hNav1.1H933PEIEE6DII S5-S6H909
hNav1.1M934IEIEE6DII S5-S6M910
hNav1.1H939PEIEE6DII S5-S6H915
hNav1.1H939QEIEE6DII S5-S6H915
hNav1.1H939YEIEE6DII S5-S6H915
hNav1.1S940FEIEE6DII S5-S6S916
hNav1.1L942PEIEE6DII S5-S6L918
hNav1.1I943NEIEE6DII S5-S6I919
hNav1.1V944AEIEE6DII S5-S6V920
hNav1.1V944EEIEE6DII S5-S6V920
hNav1.1F945LEIEE6DII S5-S6F921
hNav1.1R946CEIEE6DII S5-S6R922
hNav1.1R946HEIEE6DII S5-S6R922
hNav1.1R946SEIEE6DII S5-S6R922
hNav1.1C949SEIEE6DII S5-S6C925
hNav1.1C949YEIEE6DII S5-S6C925
hNav1.1G950EEIEE6DII S5-S6G926
hNav1.1G950REIEE6DII S5-S6G926
hNav1.1W952GEIEE6DII S5-S6W928
hNav1.1E954KEIEE6DII S5-S6E930
hNav1.1M956KEIEE6DII S5-S6M932
hNav1.1W957LEIEE6DII S5-S6W933
hNav1.1C959REIEE6DII S5-S6C935
hNav1.1M960VEIEE6DII S5-S6M936
hNav1.1M973KEIEE6DII S6M949
hNav1.1M976IEIEE6DII S6M952
hNav1.1G979VEIEE6DII S6G955
hNav1.1N985IEIEE6DII S6N961
hNav1.1L986FEIEE6DII S6L962
hNav1.1L986PEIEE6DII S6L962
hNav1.1F987LEIEE6DII S6F963
hNav1.1S993REIEE6DII - DIIIS969
hNav1.1D998GEIEE6DII - DIIID974
hNav1.1E1068KEIEE6DII - DIIIE1045
hNav1.1L1207PEIEE6DII - DIIII1181
hNav1.1R1208KEIEE6DII - DIIIR1182
hNav1.1T1210KEIEE6DII - DIIIT1184
hNav1.1E1221KEIEE6DIII S1E1195
hNav1.1L1230FEIEE6DIII S1L1204
hNav1.1S1231REIEE6DIII S1S1205
hNav1.1S1231TEIEE6DIII S1S1205
hNav1.1G1233REIEE6DIII S1G1207
hNav1.1E1238DEIEE6DIII S1-S2E1212
hNav1.1D1239GEIEE6DIII S1-S2D1213
hNav1.1D1239YEIEE6DIII S1-S2D1213
hNav1.1R1245QEIEE6DIII S1-S2K1219
hNav1.1A1255DEIEE6DIII S2A1229
hNav1.1T1260PEIEE6DIII S2T1234
hNav1.1F1263LEIEE6DIII S2F1237
hNav1.1L1265PEIEE6DIII S2L1239
hNav1.1E1266AEIEE6DIII S2E1240
hNav1.1G1275VEIEE6DIII S2-S3G1249
hNav1.1W1284SEIEE6DIII S3W1258
hNav1.1L1287PEIEE6DIII S3L1261
hNav1.1D1288NEIEE6DIII S3D1262
hNav1.1R1316GEIEE6DIII S4R1290
hNav1.1R1316SEIEE6DIII S4R1290
hNav1.1A1320VEIEE6DIII S4A1294
hNav1.1A1326PEIEE6DIII S4A1300
hNav1.1S1328PEIEE6DIII S4-S5S1302
hNav1.1V1335MEIEE6DIII S4-S5V1309
hNav1.1A1339VEIEE6DIII S4-S5A1313
hNav1.1I1344MEIEE6DIII S4-S5I1318
hNav1.1V1350GEIEE6DIII S5V1324
hNav1.1L1355PEIEE6DIII S5L1329
hNav1.1W1358REIEE6DIII S5W1332
hNav1.1W1358SEIEE6DIII S5W1332
hNav1.1N1367KEIEE6DIII S5N1341
hNav1.1A1370PEIEE6DIII S5-S6A1344
hNav1.1N1378HEIEE6DIII S5-S6N1352
hNav1.1N1378TEIEE6DIII S5-S6N1352
hNav1.1F1385VEIEE6DIII S5-S6F1359
hNav1.1V1390MEIEE6DIII S5-S6V1364
hNav1.1N1391SEIEE6DIII S5-S6P1365
hNav1.1H1393PEIEE6DIII S5-S6R1367
hNav1.1T1394IEIEE6DIII S5-S6S1368
hNav1.1C1396GEIEE6DIII S5-S6C1370
hNav1.1C1396YEIEE6DIII S5-S6C1370
hNav1.1N1414YEIEE6DIII S5-S6N1388
hNav1.1D1416GEIEE6DIII S5-S6D1390
hNav1.1N1417SEIEE6DIII S5-S6N1391
hNav1.1V1418GEIEE6DIII S5-S6V1392
hNav1.1Y1422CEIEE6DIII S5-S6Y1396
hNav1.1L1423FEIEE6DIII S5-S6L1397
hNav1.1L1426REIEE6DIII S5-S6L1400
hNav1.1Q1427PEIEE6DIII S5-S6Q1401
hNav1.1F1431IEIEE6DIII S5-S6F1405
hNav1.1G1433EEIEE6DIII S5-S6G1407
hNav1.1G1433REIEE6DIII S5-S6G1407
hNav1.1G1433VEIEE6DIII S5-S6G1407
hNav1.1W1434REIEE6DIII S5-S6W1408
hNav1.1I1437MEIEE6DIII S5-S6I1411
hNav1.1A1441PEIEE6DIII S5-S6A1415
hNav1.1Q1450KEIEE6DIII S5-S6Q1424
hNav1.1Q1450REIEE6DIII S5-S6Q1424
hNav1.1P1451LEIEE6DIII S5-S6P1425
hNav1.1P1451SEIEE6DIII S5-S6P1425
hNav1.1Y1453CEIEE6DIII S5-S6Y1427
hNav1.1E1454KEIEE6DIII S5-S6E1428
hNav1.1L1461IEIEE6DIII S6I1435
hNav1.1Y1462CEIEE6DIII S6Y1436
hNav1.1Y1462HEIEE6DIII S6Y1436
hNav1.1F1463SEIEE6DIII S6F1437
hNav1.1G1470WEIEE6DIII S6G1444
hNav1.1F1472SEIEE6DIII S6F1446
hNav1.1L1475SEIEE6DIII S6L1449
hNav1.1N1476KEIEE6DIII S6N1450
hNav1.1D1484GEIEE6DIII S6D1458
hNav1.1N1485YEIEE6DIII S6N1459
hNav1.1E1503KEIEE6DIII - DIVE1477
hNav1.1L1514SEIEE6DIII - DIVL1488
hNav1.1V1538IEIEE6DIII - DIVV1512
hNav1.1D1544AEIEE6DIV S1D1518
hNav1.1D1544GEIEE6DIV S1D1518
hNav1.1I1545VEIEE6DIV S1I1519
hNav1.1M1555REIEE6DIV S1M1529
hNav1.1E1561KEIEE6DIV S1-S2E1535
hNav1.1V1579EEIEE6DIV S2V1553
hNav1.1G1586EEIEE6DIV S2G1560
hNav1.1C1588REIEE6DIV S2C1562
hNav1.1L1592HEIEE6DIV S2L1566
hNav1.1L1592PEIEE6DIV S2L1566
hNav1.1R1596CEIEE6DIV S2-S3R1570
hNav1.1R1596LEIEE6DIV S2-S3R1570
hNav1.1N1605SEIEE6DIV S3N1579
hNav1.1D1608GEIEE6DIV S3D1582
hNav1.1D1608YEIEE6DIV S3D1582
hNav1.1V1612IEIEE6DIV S3V1586
hNav1.1V1630LEIEE6DIV S3-S4V1604
hNav1.1V1630MEIEE6DIV S3-S4V1604
hNav1.1V1637EEIEE6DIV S4V1611
hNav1.1I1638NEIEE6DIV S4I1612
hNav1.1I1638TEIEE6DIV S4I1612
hNav1.1R1639GEIEE6DIV S4R1613
hNav1.1R1642SEIEE6DIV S4R1616
hNav1.1R1645QEIEE6DIV S4R1619
hNav1.1R1648CEIEE6DIV S4R1622
hNav1.1R1648HEIEE6DIV S4R1622
hNav1.1A1653EEIEE6DIV S4-S5A1627
hNav1.1T1658MEIEE6DIV S5T1632
hNav1.1T1658REIEE6DIV S5T1632
hNav1.1L1660PEIEE6DIV S5L1634
hNav1.1F1661SEIEE6DIV S5F1635
hNav1.1A1662VEIEE6DIV S5A1636
hNav1.1M1664KEIEE6DIV S5M1638
hNav1.1L1667PEIEE6DIV S5L1641
hNav1.1P1668AEIEE6DIV S5P1642
hNav1.1P1668LEIEE6DIV S5P1642
hNav1.1N1672IEIEE6DIV S5N1646
hNav1.1I1673TEIEE6DIV S5I1647
hNav1.1G1674REIEE6DIV S5G1648
hNav1.1L1675REIEE6DIV S5L1649
hNav1.1L1677FEIEE6DIV S5L1651
hNav1.1I1683TEIEE6DIV S5I1657
hNav1.1Y1684DEIEE6DIV S5Y1658
hNav1.1A1685DEIEE6DIV S5A1659
hNav1.1G1688WEIEE6DIV S5G1662
hNav1.1F1692SEIEE6DIV S5F1666
hNav1.1Y1694CEIEE6DIV S5-S6Y1668
hNav1.1F1707VEIEE6DIV S5-S6F1681
hNav1.1S1713NEIEE6DIV S5-S6S1687
hNav1.1M1714KEIEE6DIV S5-S6M1688
hNav1.1M1714REIEE6DIV S5-S6M1688
hNav1.1C1716REIEE6DIV S5-S6C1690
hNav1.1T1721REIEE6DIV S5-S6T1695
hNav1.1G1725CEIEE6DIV S5-S6G1699
hNav1.1W1726REIEE6DIV S5-S6W1700
hNav1.1D1727GEIEE6DIV S5-S6D1701
hNav1.1C1741REIEE6DIV S5-S6C1715
hNav1.1G1749EEIEE6DIV S5-S6G1723
hNav1.1C1756GEIEE6DIV S5-S6C1730
hNav1.1G1762EEIEE6DIV S6G1736
hNav1.1I1763NEIEE6DIV S6I1737
hNav1.1I1770FEIEE6DIV S6I1744
hNav1.1I1770NEIEE6DIV S6I1744
hNav1.1I1770TEIEE6DIV S6I1744
hNav1.1I1771FEIEE6DIV S6I1745
hNav1.1I1771NEIEE6DIV S6I1745
hNav1.1S1773FEIEE6DIV S6S1747
hNav1.1M1780TEIEE6DIV S6M1754
hNav1.1Y1781CEIEE6DIV S6Y1755
hNav1.1Y1781HEIEE6DIV S6Y1755
hNav1.1I1782MEIEE6DIV S6I1756
hNav1.1I1782SEIEE6DIV S6I1756
hNav1.1A1783TEIEE6DIV S6A1757
hNav1.1A1783VEIEE6DIV S6A1757
hNav1.1E1787KEIEE6DIV S6E1761
hNav1.1N1788KEIEE6DIV S6N1862
hNav1.1A1792TEIEE6C-terminusA1766
hNav1.1F1808IEIEE6C-terminusF1782
hNav1.1W1812GEIEE6C-terminusW1786
hNav1.1W1812SEIEE6C-terminusW1786
hNav1.1F1831SEIEE6C-terminusF1805
hNav1.1A1832PEIEE6C-terminusA1806
hNav1.1L1835FEIEE6C-terminusL1809
hNav1.1M1852KEIEE6C-terminusM1826
hNav1.1P1855LEIEE6C-terminusP1829
hNav1.1G1880EEIEE6C-terminusG1854
hNav1.1E1881DEIEE6C-terminusE1855
hNav1.1T1909IEIEE6C-terminusT1883
hNav1.1I1922TEIEE6C-terminusI1896
hNav1.1F90SICEGTCN-terminusF88
hNav1.1R101QICEGTCN-terminusR99
hNav1.1F178SICEGTCDI S2-S3F176
hNav1.1I252MICEGTCDI S5I250
hNav1.1H290RICEGTCDI S5-S6S288
hNav1.1R393HICEGTCDI S5-S6R372
hNav1.1T808SICEGTCDII S2T784
hNav1.1V896IICEGTCDII S5V872
hNav1.1V944AICEGTCDII S5-S6R920
hNav1.1G979RICEGTCDII S6G955
hNav1.1V983AICEGTCDII S6V959
hNav1.1N1011IICEGTCDII - DIIIN987
hNav1.1R1213QICEGTCDII - DIIIK1187
hNav1.1Y1254CICEGTCDIII S2Y1228
hNav1.1R1325TICEGTCDIII S4R1299
hNav1.1S1328PICEGTCDIII S4-S5S1302
hNav1.1F1357LICEGTCDIII S5F1331
hNav1.1V1366IICEGTCDIII S5V1340
hNav1.1C1376RICEGTCDIII S5-S6C1350
hNav1.1A1429DICEGTCDIII S5-S6A1403
hNav1.1Y1462HICEGTCDIII S6Y1436
hNav1.1M1511KICEGTCDIII - DIVM1485
hNav1.1V1611FICEGTCDIV S3V1585
hNav1.1M1619VICEGTCDIV S3M1593
hNav1.1P1632SICEGTCDIV S3-S4P1606
hNav1.1Y1684SICEGTCDIV S5Y1658
hNav1.1T1709IICEGTCDIV S5-S6T1683
hNav1.1A1724PICEGTCDIV S5-S6A1698
hNav1.1Y1781CICEGTCDIV S6Y1755
hNav1.1F1808LICEGTCC-terminusF1782
hNav1.1R1861WICEGTCC-terminusR1835
hNav1.1T1174SFHM3DII - DIIIS1148
hNav1.1Q1489HFHM3DIII S6Q1463
hNav1.1Q1489KFHM3DIII S6Q1463
hNav1.1F1499LFHM3DIII - DIVF1473
hNav1.1L1649QFHM3DIV S4L1623
hNav1.1M145TFEB3ADI S1M143
hNav1.1E1308DFEB3ADIII S3-S4D1282

GEFS+2: Generalized epilepsy with febrile seizures plus 2; EIEE6: Epileptic encephalopathy, early infantile, 6; ICEGTC: Intractable childhood epilepsy with generalized tonic-clonic seizures; FHM3: Migraine, familial hemiplegic, 3; FEB3A: Febrile seizures, familial, 3A

Table 3

Structural mapping of disease-related mutations identified in human Nav1.2

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.2E169GEIEE11DI S2E166
hNav1.2R188WBFIS3DI S3R185
hNav1.2V208EBFIS3DI S3-S4V205
hNav1.2N212DEIEE11DI S3-S4N209
hNav1.2V213DEIEE11DI S3-S4V210
hNav1.2R223QBFIS3DI S4R220
hNav1.2T236SEIEE11DI S5T233
hNav1.2M252VBFIS3DI S5M249
hNav1.2V261MBFIS3DI S5V258
hNav1.2A263TEIEE11DI S5A260
hNav1.2A263VEIEE11DI S5A260
hNav1.2D322NDSDI - DIID298
hNav1.2F328VDSDI - DIIY305
hNav1.2E430QBFIS3DI - DIIE407
hNav1.2D649NDSDI - DIID623
hNav1.2R853QEIEE11DII S4R838
hNav1.2N876TEIEE11DII S5N861
hNav1.2V892IBFIS3DII S5V877
hNav1.2E999KEIEE11DII - DIIID984
hNav1.2N1001KBFIS3DII - DIIIN986
hNav1.2L1003IBFIS3DII - DIIIL988
hNav1.2E1211KEIEE11DIII S1E1195
hNav1.2R1312TEIEE11DIII S4R1296
hNav1.2R1312TDSDIII S4R1296
hNav1.2R1319QBFIS3DIII S4-S5R1303
hNav1.2M1323VEIEE11DIII S4-S5M1307
hNav1.2V1326LEIEE11DIII S4-S5V1310
hNav1.2V1326DEIEE11DIII S4-S5V1310
hNav1.2L1330FBFIS3DIII S4-S5L1314
hNav1.2S1336YEIEE11DIII S4-S5S1320
hNav1.2M1338TEIEE11DIII S5M1322
hNav1.2L1342PBFIS3DIII S5L1326
hNav1.2I1473MEIEE11DIII S6I1457
hNav1.2L1563VBFIS3DIV S2L1547
hNav1.2Y1589CBFIS3DIV S2-S3Y1573
hNav1.2I1596SBFIS3DIV S3I1580
hNav1.2T1623NEIEE11DIV S3-S4T1607
hNav1.2R1629LEIEE11DIV S4R1613
hNav1.2L1660YEIEE11DIV S5L1644
hNav1.2R1918HBFIS3C-terminusR1902

BFIS3: Seizures, benign familial infantile 3; EIEE11: Epileptic encephalopathy, early infantile, 11; DS: Dravet syndrome

Table 4

Structural mapping of disease-related mutations identified in human Nav1.3

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.3K354QCPEDI - DIIK332
hNav1.3R357QCPEDI - DIIR335
hNav1.3D815NCPEDII S2-S3D799
hNav1.3E1160KCPEDII - DIIIM1146
hNav1.3M1372VCPEDIII S5-S6R1358
hNav1.3G1862CCPEC-terminusG1851

CPE: Cryptogenic partial epilepsy

Table 5

Structural mapping of disease-related mutations identified in human Nav1.4

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.4Q270KPMCDI S5Q265
hNav1.4I693TPMCDII S5I858
hNav1.4T704MPMCDII S5T870
hNav1.4S804FPMCDII - DIIIS970
hNav1.4A1152DPMCDIII S4-S5A1313
hNav1.4A1156TPMCDIII S4-S5A1317
hNav1.4V1293IPMCDIII S6V1455
hNav1.4G1306APMCDIII S6G1468
hNav1.4G1306EPMCDIII S6G1468
hNav1.4G1306VPMCDIII S6G1468
hNav1.4T1313MPMCDIII - DIVT1475
hNav1.4L1433RPMCDIV S3L1595
hNav1.4L1436PPMCDIV S3L1598
hNav1.4R1448CPMCDIV S4R1610
hNav1.4R1448HPMCDIV S4R1610
hNav1.4R1448LPMCDIV S4R1610
hNav1.4G1456EPMCDIV S4G1618
hNav1.4F1473SPMCDIV S5F1635
hNav1.4V1589MPMCDIV S6V1751
hNav1.4F1705IPMCC-terminusF1867
hNav1.4R222WHOKPP2DI S4E217
hNav1.4R669HHOKPP2DII S4R835
hNav1.4R672CHOKPP2DII S4R838
hNav1.4R672GHOKPP2DII S4R838
hNav1.4R672HHOKPP2DII S4R838
hNav1.4R672SHOKPP2DII S4R838
hNav1.4R1129QHOKPP2DIII S4R1290
hNav1.4R1132QHOKPP2DIII S4R1293
hNav1.4R1135CHOKPP2DIII S4R1296
hNav1.4R1135HHOKPP2DIII S4R1299
hNav1.4P1158SHOKPP2DIII S4-S5P1319
hNav1.4T704MHYPPDII S5T870
hNav1.4V781IHYPPDII S6V947
hNav1.4A1156THYPPDIII S4-S5A1317
hNav1.4L1433RHYPPDIV S3L1595
hNav1.4M1592VHYPPDIV S6M1754
hNav1.4R675GNKPPDII S4R841
hNav1.4R675QNKPPDII S4R841
hNav1.4R675WNKPPDII S4R841
hNav1.4V781INKPPDII S6V947
hNav1.4R1129QNKPPDIII S4R1290
hNav1.4M1592VNKPPDIV S6M1754
hNav1.4I141VMYOSCN4ADI S1I136
hNav1.4R225WMYOSCN4ADI S4R220
hNav1.4N440KMYOSCN4ADI S6N395
hNav1.4V445MMYOSCN4ADI - DIIV440
hNav1.4E452KMYOSCN4ADI - DIIE447
hNav1.4I588VMYOSCN4ADII S1I754
hNav1.4F671SMYOSCN4ADII S4F837
hNav1.4A715TMYOSCN4ADII S5A881
hNav1.4S804NMYOSCN4ADII - DIIIS970
hNav1.4A1156TMYOSCN4ADIII S4-S5A1317
hNav1.4P1158LMYOSCN4ADIII S4-S5P1319
hNav1.4I1160VMYOSCN4ADIII S4-S5I1321
hNav1.4N1297KMYOSCN4ADIII S6I1457
hNav1.4G1306EMYOSCN4ADIII S6G1468
hNav1.4G1306VMYOSCN4ADIII S6G1468
hNav1.4I1310NMYOSCN4ADIII - DIVI1472
hNav1.4M1476IMYOSCN4ADIV S5M1638
hNav1.4A1481DMYOSCN4ADIV S5A1643
hNav1.4Q1633EMYOSCN4AC-terminusQ1795
hNav1.4R104HCMS16N-terminusR99
hNav1.4M203KCMS16DI S3F198
hNav1.4R225WCMS16DI S4R220
hNav1.4S246LCMS16DI S5S241
hNav1.4P382TCMS16DI S5-S6P337
hNav1.4D1069NCMS16DIII S2D1230
hNav1.4R1135CCMS16DIII S4-S5R1299
hNav1.4C1209FCMS16DIII S5-S6C1370
hNav1.4V1442ECMS16DIV S3-S4V1604
hNav1.4R1454WCMS16DIV S4R1616
hNav1.4R1457HCMS16DIV S4R1619

PMC: Paramyotonia congenita of von Eulenburg; HOKPP2: Periodic paralysis hypokalemic 2; HYPP: Periodic paralysis hyperkalemic; NKPP: Periodic paralysis normokalemic; MYOSCN4A: Myotonia SCN4A-related; CMS16: Myasthenic syndrome, congenital, 16

Table 6

Structural mapping of disease-related mutations identified in human Nav1.5

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.5E161KPFHB1ADI S2E156
hNav1.5R225WPFHB1ADI S4R220
hNav1.5G298SPFHB1ADI S4-S5
hNav1.5T512IPFHB1ADI - DIIV518
hNav1.5G514CPFHB1ADI - DIIG520
hNav1.5G752RPFHB1ADII S2-S3G779
hNav1.5R1232WPFHB1ADIII S1-S2K1219
hNav1.5D1275NPFHB1ADIII S3D1262
hNav1.5D1595NPFHB1ADIII D3-S4D1582
hNav1.5T1620KPFHB1ADIV S3-S4T1607
hNav1.5G9VLQT3N-terminusG8
hNav1.5R18QLQT3N-terminusK17
hNav1.5R27HLQT3N-terminusR26
hNav1.5E30GLQT3N-terminusE29
hNav1.5R43QLQT3N-terminusK40
hNav1.5E48KLQT3N-terminusD43
hNav1.5P52SLQT3N-terminusP47
hNav1.5R53QLQT3N-terminusK48
hNav1.5R104GLQT3N-terminusR99
hNav1.5S115GLQT3N-terminusS110
hNav1.5V125LLQT3N-terminusI125
hNav1.5L212PLQT3DI S3-S4L207
hNav1.5R222QLQT3DI S4R217
hNav1.5R225QLQT3DI S4R220
hNav1.5R225WLQT3DI S4R220
hNav1.5V240MLQT3DI S5V235
hNav1.5Q245KLQT3DI S5Q240
hNav1.5V247LLQT3DI S5L242
hNav1.5N275KLQT3DI S5-S6N270
hNav1.5G289SLQT3DI S5-S6E284
hNav1.5R340WLQT3DI S5-S6T329
hNav1.5R367CLQT3DI S5-S6R356
hNav1.5T370MLQT3DI S5-S6T359
hNav1.5I397TLQT3DI S6I386
hNav1.5L404QLQT3DI S6L393
hNav1.5N406KLQT3DI S6N395
hNav1.5L409VLQT3DI S6L398
hNav1.5V411MLQT3DI S6V400
hNav1.5A413ELQT3DI S6A402
hNav1.5A413TLQT3DI S6A402
hNav1.5E462ALQT3DI - DIIE464
hNav1.5E462KLQT3DI - DIIE464
hNav1.5F530VLQT3DI - DIIF555
hNav1.5R535QLQT3DI - DIIR562
hNav1.5R569WLQT3DI - DIIE596
hNav1.5S571ILQT3DI - DIIR598
hNav1.5A572DLQT3DI - DIIS599
hNav1.5A572SLQT3DI - DIIS599
hNav1.5A572VLQT3DI - DIIS599
hNav1.5Q573ELQT3DI - DIIS600
hNav1.5G579RLQT3DI - DIIS606
hNav1.5G615ELQT3DI - DIIN641
hNav1.5L619FLQT3DI - DIIL615
hNav1.5P637LLQT3DI - DII
hNav1.5G639RLQT3DI - DIIK666
hNav1.5P648LLQT3DI - DIIL675
hNav1.5E654KLQT3DI - DIIN681
hNav1.5L673PLQT3DI - DIIV700
hNav1.5R680HLQT3DI - DIIQ708
hNav1.5R689CLQT3DI - DIIR716
hNav1.5R689HLQT3DI - DIIR716
hNav1.5P701LLQT3DI - DIIP728
hNav1.5T731ILQT3DII S1T758
hNav1.5Q750RLQT3DII S2A777
hNav1.5D772NLQT3DII S2-S3D799
hNav1.5F816YLQT3DII S4F843
hNav1.5I848FLQT3DII S5I875
hNav1.5S941NLQT3DII - DIIIS970
hNav1.5Q960KLQT3DII - DIIIQ989
hNav1.5R965LLQT3DII - DIIIR994
hNav1.5R971CLQT3DII - DIIIN1000
hNav1.5C981FLQT3DII - DIII
hNav1.5A997SLQT3DII - DIIIE1023
hNav1.5C1004RLQT3DII - DIIIY1037
hNav1.5E1053KLQT3DII - DIIIE1095
hNav1.5T1069MLQT3DII - DIIID1111
hNav1.5A1100VLQT3DII - DIII
hNav1.5D1114NLQT3DII - DIII
hNav1.5D1166NLQT3DII - DIIIA1153
hNav1.5R1193QLQT3DII - DIIIN1180
hNav1.5Y1199SLQT3DII - DIIIY1186
hNav1.5E1225KLQT3DIII S1-S2E1212
hNav1.5E1231KLQT3DIII S1-S2R1218
hNav1.5F1250LLQT3DIII S2F1237
hNav1.5L1283MLQT3DIII S3L1270
hNav1.5E1295KLQT3DIII S3-S4D1282
hNav1.5T1304MLQT3DIII S4T1291
hNav1.5N1325SLQT3DIII S4-S5N1312
hNav1.5A1326SLQT3DIII S4-S5A1313
hNav1.5A1330PLQT3DIII S4-S5A1317
hNav1.5A1330TLQT3DIII S4-S5A1317
hNav1.5P1332LLQT3DIII S4-S5P1319
hNav1.5S1333YLQT3DIII S4-S5S1320
hNav1.5I1334VLQT3DIII S4-S5I1321
hNav1.5L1338VLQT3DIII S5L1325
hNav1.5R1432SLQT3DIII S5-S6V1419
hNav1.5S1458YLQT3DIII S6S1445
hNav1.5N1472SLQT3DIII S6N1459
hNav1.5F1473CLQT3DIII S6F1460
hNav1.5G1481ELQT3DIII - DIVG1468
hNav1.5F1486LLQT3DIII - DIVF1473
hNav1.5M1487LLQT3DIII - DIVM1474
hNav1.5T1488RLQT3DIII - DIVT1475
hNav1.5E1489DLQT3DIII - DIVE1476
hNav1.5K1493RLQT3DIII - DIVK1480
hNav1.5Y1495SLQT3DIII - DIVY1482
hNav1.5M1498VLQT3DIII - DIVM1485
hNav1.5L1501VLQT3DIII - DIVL1488
hNav1.5K1505NLQT3DIII - DIVK1492
hNav1.5V1532ILQT3DIV S1I1519
hNav1.5L1560FLQT3DIV S2L1547
hNav1.5I1593MLQT3DIV S3I1580
hNav1.5F1594SLQT3DIV S3F1581
hNav1.5D1595NLQT3DIV S3D1582
hNav1.5F1596ILQT3DIV S3F1583
hNav1.5S1609WLQT3DIV S3A1596
hNav1.5T1620KLQT3DIV S3-S4T1607
hNav1.5R1623LLQT3DIV S4R1610
hNav1.5R1623QLQT3DIV S4R1610
hNav1.5R1626HLQT3DIV S4R1613
hNav1.5R1626PLQT3DIV S4R1613
hNav1.5R1644CLQT3DIV S5R1631
hNav1.5R1644HLQT3DIV S5R1631
hNav1.5T1645MLQT3DIV S5T1632
hNav1.5L1650FLQT3DIV S5L1637
hNav1.5M1652RLQT3DIV S5M1639
hNav1.5M1652TLQT3DIV S5M1639
hNav1.5I1660VLQT3DIV S5I1647
hNav1.5V1667ILQT3DIV S5V1654
hNav1.5T1723NLQT3DIV S5-S6S1710
hNav1.5R1739WLQT3DIV S5-S6E1727
hNav1.5L1761FLQT3DIV S6L1749
hNav1.5L1761HLQT3DIV S6L1749
hNav1.5V1763MLQT3DIV S6V1751
hNav1.5M1766LLQT3DIV S6M1754
hNav1.5Y1767CLQT3DIV S6Y1755
hNav1.5I1768VLQT3DIV S6I1756
hNav1.5V1777MLQT3C-terminusV1765
hNav1.5T1779MLQT3C-terminusT1767
hNav1.5E1784KLQT3C-terminusE1772
hNav1.5D1790GLQT3C-terminusD1778
hNav1.5Y1795CLQT3C-terminusY1783
hNav1.5Y1795YDLQT3C-terminusY1783
hNav1.5D1819NLQT3C-terminusA1807
hNav1.5L1825PLQT3C-terminusL1813
hNav1.5R1826HLQT3C-terminusL1814
hNav1.5D1839GLQT3C-terminusD1827
hNav1.5R1897WLQT3C-terminusK1885
hNav1.5E1901QLQT3C-terminusE1889
hNav1.5S1904LLQT3C-terminusS1892
hNav1.5Q1909RLQT3C-terminusQ1897
hNav1.5R1913HLQT3C-terminusR1901
hNav1.5A1949SLQT3C-terminusF1934
hNav1.5V1951LLQT3C-terminusN1936
hNav1.5Y1977NLQT3C-terminusY1958
hNav1.5F2004LLQT3C-terminusD1982
hNav1.5F2004VLQT3C-terminusD1982
hNav1.5R2012CLQT3C-terminus
hNav1.5R18QBRGDA1N-terminusK17
hNav1.5R27HBRGDA1N-terminusR26
hNav1.5N70KBRGDA1N-terminusD65
hNav1.5D84NBRGDA1N-terminusD79
hNav1.5F93SBRGDA1N-terminusF88
hNav1.5I94SBRGDA1N-terminusI89
hNav1.5V95IBRGDA1N-terminusV90
hNav1.5R104QBRGDA1N-terminusR99
hNav1.5R104WBRGDA1N-terminusR99
hNav1.5N109KBRGDA1N-terminusP104
hNav1.5R121QBRGDA1N-terminusR116
hNav1.5R121WBRGDA1N-terminusR116
hNav1.5K126EBRGDA1N-terminusK121
hNav1.5L136PBRGDA1DI S1L131
hNav1.5V146MBRGDA1DI S1I141
hNav1.5E161KBRGDA1DI S2E156
hNav1.5E161QBRGDA1DI S2E156
hNav1.5K175NBRGDA1DI S2K170
hNav1.5A178GBRGDA1DI S2-S3A173
hNav1.5C182RBRGDA1DI S2-S3C177
hNav1.5A185VBRGDA1DI S2-S3E180
hNav1.5T187IBRGDA1DI S3T182
hNav1.5A204VBRGDA1DI S3A199
hNav1.5L212QBRGDA1DI S3-S4L207
hNav1.5T220IBRGDA1DI S4T215
hNav1.5R222QBRGDA1DI S4R217
hNav1.5V223LBRGDA1DI S4V218
hNav1.5R225WBRGDA1DI S4R220
hNav1.5A226VBRGDA1DI S4A221
hNav1.5I230VBRGDA1DI S4T225
hNav1.5V232IBRGDA1DI S4V227
hNav1.5V240MBRGDA1DI S5V235
hNav1.5Q270KBRGDA1DI S5Q265
hNav1.5L276QBRGDA1DI S5-S6L271
hNav1.5H278DBRGDA1DI S5-S6H273
hNav1.5R282CBRGDA1DI S5-S6R277
hNav1.5R282HBRGDA1DI S5-S6R277
hNav1.5V294MBRGDA1DI S5-S6I289
hNav1.5V300IBRGDA1DI S5-S6
hNav1.5L315PBRGDA1DI S5-S6Y304
hNav1.5G319SBRGDA1DI S5-S6G308
hNav1.5T320NBRGDA1DI S5-S6S319
hNav1.5L325RBRGDA1DI S5-S6L314
hNav1.5P336LBRGDA1DI S5-S6P325
hNav1.5G351DBRGDA1DI S5-S6G340
hNav1.5G351VBRGDA1DI S5-S6G340
hNav1.5T353IBRGDA1DI S5-S6T342
hNav1.5D356NBRGDA1DI S5-S6D345
hNav1.5R367CBRGDA1DI S5-S6R356
hNav1.5R367HBRGDA1DI S5-S6R356
hNav1.5R367LBRGDA1DI S5-S6R356
hNav1.5M369KBRGDA1DI S5-S6M358
hNav1.5W374GBRGDA1DI S5-S6W363
hNav1.5R376HBRGDA1DI S5-S6N365
hNav1.5G386EBRGDA1DI S5-S6G375
hNav1.5G386RBRGDA1DI S5-S6G375
hNav1.5V396ABRGDA1DI S6V385
hNav1.5V396LBRGDA1DI S6V385
hNav1.5N406SBRGDA1DI S6N395
hNav1.5E439KBRGDA1DI - DIID428
hNav1.5D501GBRGDA1DI - DIID507
hNav1.5G514CBRGDA1DI - DIIG520
hNav1.5R526HBRGDA1DI - DIIR540
hNav1.5F532CBRGDA1DI - DIIA546
hNav1.5F543LBRGDA1DI - DIIF570
hNav1.5G552RBRGDA1DI - DIIG579
hNav1.5L567QBRGDA1DI - DIIP594
hNav1.5G615EBRGDA1DI - DIIN641
hNav1.5L619FBRGDA1DI - DIIL615
hNav1.5R620CBRGDA1DI - DIIE647
hNav1.5T632MBRGDA1DI - DIIG659
hNav1.5P640ABRGDA1DI - DIIK667
hNav1.5A647DBRGDA1DI - DIIL674
hNav1.5P648LBRGDA1DI - DIIL675
hNav1.5R661WBRGDA1DI - DIIR688
hNav1.5H681PBRGDA1DI - DIIQ708
hNav1.5C683GBRGDA1DI - DIIC710
hNav1.5P701LBRGDA1DI - DIIP728
hNav1.5P717LBRGDA1DI - DIIP744
hNav1.5A735EBRGDA1DII S1-S2A762
hNav1.5A735VBRGDA1DII S1-S2A762
hNav1.5E746KBRGDA1DII S2K773
hNav1.5G752RBRGDA1DII S2G779
hNav1.5G758EBRGDA1DII S2G785
hNav1.5M764RBRGDA1DII S2M791
hNav1.5D772NBRGDA1DII S2-S3D799
hNav1.5P773SBRGDA1DII S2-S3P800
hNav1.5V789IBRGDA1DII S3V816
hNav1.5R808PBRGDA1DII S4R835
hNav1.5R814QBRGDA1DII S4R841
hNav1.5L839PBRGDA1DII S6L866
hNav1.5F851LBRGDA1DII S6F878
hNav1.5E867QBRGDA1DII S5-S6E894
hNav1.5R878CBRGDA1DII S5-S6R907
hNav1.5R878HBRGDA1DII S5-S6R907
hNav1.5H886PBRGDA1DII S5-S6H915
hNav1.5F892IBRGDA1DII S5-S6F921
hNav1.5R893CBRGDA1DII S5-S6R922
hNav1.5R893HBRGDA1DII S5-S6R922
hNav1.5C896SBRGDA1DII S5-S6C925
hNav1.5E901KBRGDA1DII S5-S6E930
hNav1.5S910LBRGDA1DII S5-S6A939
hNav1.5C915RBRGDA1DII S5-S6C944
hNav1.5L917RBRGDA1DII S6I946
hNav1.5N927SBRGDA1DII S6N956
hNav1.5L928PBRGDA1DII S6L957
hNav1.5L935PBRGDA1DII S6L964
hNav1.5R965CBRGDA1DII - DIIIR994
hNav1.5R965HBRGDA1DII - DIIIR994
hNav1.5A997TBRGDA1DII - DIIIQ1026
hNav1.5R1023HBRGDA1DII - DIIIH1050
hNav1.5E1053KBRGDA1DII - DIIIE1095
hNav1.5D1055GBRGDA1DII - DIIID1097
hNav1.5S1079YBRGDA1DII - DIII
hNav1.5A1113VBRGDA1DII - DIII
hNav1.5S1140TBRGDA1DII - DIIIS1128
hNav1.5R1193QBRGDA1DII - DIIIN1180
hNav1.5S1219NBRGDA1DIII S1S1206
hNav1.5E1225KBRGDA1DIII S1-S2E1212
hNav1.5Y1228HBRGDA1DIII S1-S2Y1215
hNav1.5R1232QBRGDA1DIII S1-S2K1219
hNav1.5R1232WBRGDA1DIII S1-S2K1219
hNav1.5K1236NBRGDA1DIII S2K1223
hNav1.5L1339PBRGDA1DIII S2L1226
hNav1.5E1240QBRGDA1DIII S2E1227
hNav1.5D1243NBRGDA1DIII S2D1230
hNav1.5V1249DBRGDA1DIII S2I1236
hNav1.5E1253GBRGDA1DIII S2E1240
hNav1.5G1262SBRGDA1DIII S2-S3G1249
hNav1.5W1271CBRGDA1DIII S3W1258
hNav1.5D1275NBRGDA1DIII S3D1262
hNav1.5A1288GBRGDA1DIII S3-S4A1275
hNav1.5F1293SBRGDA1DIII S3-S4Y1280
hNav1.5L1311PBRGDA1DIII S4L1298
hNav1.5G1319VBRGDA1DIII S4-S5G1306
hNav1.5V1323GBRGDA1DIII S4-S5V1310
hNav1.5P1332LBRGDA1DIII S4-S5P1319
hNav1.5F1344LBRGDA1DIII S5F1331
hNav1.5F1344SBRGDA1DIII S5F1331
hNav1.5L1346IBRGDA1DIII S5L1333
hNav1.5L1346PBRGDA1DIII S5L1333
hNav1.5M1351RBRGDA1DIII S5M1338
hNav1.5V1353MBRGDA1DIII S5V1340
hNav1.5G1358WBRGDA1DIII S5-S6G1345
hNav1.5K1359NBRGDA1DIII S5-S6K1346
hNav1.5F1360CBRGDA1DIII S5-S6F1347
hNav1.5C1363YBRGDA1DIII S5-S6C1350
hNav1.5S1382IBRGDA1DIII S5-S6E1369
hNav1.5V1405LBRGDA1DIII S5-S6V1392
hNav1.5V1405MBRGDA1DIII S5-S6V1392
hNav1.5G1406EBRGDA1DIII S5-S6G1393
hNav1.5G1406RBRGDA1DIII S5-S6G1393
hNav1.5G1408RBRGDA1DIII S5-S6G1395
hNav1.5Y1409CBRGDA1DIII S5-S6Y1396
hNav1.5L1412FBRGDA1DIII S5-S6L1399
hNav1.5K1419EBRGDA1DIII S5-S6K1406
hNav1.5G1420RBRGDA1DIII S5-S6G1407
hNav1.5A1427SBRGDA1DIII S5-S6A1414
hNav1.5A1428VBRGDA1DIII S5-S6A1415
hNav1.5R1432GBRGDA1DIII S5-S6V1419
hNav1.5R1432SBRGDA1DIII S5-S6V1419
hNav1.5G1433VBRGDA1DIII S5-S6N1420
hNav1.5P1438LBRGDA1DIII S5-S6P1425
hNav1.5E1441QBRGDA1DIII S5-S6E1428
hNav1.5I1448LBRGDA1DIII S6I1435
hNav1.5I1448TBRGDA1DIII S6I1435
hNav1.5Y1449CBRGDA1DIII S6Y1436
hNav1.5V1451DBRGDA1DIII S6V1438
hNav1.5N1463YBRGDA1DIII S6N1450
hNav1.5V1468FBRGDA1DIII S6V1455
hNav1.5Y1494NBRGDA1DIII - DIVY1481
hNav1.5L1501VBRGDA1DIII - DIVL1488
hNav1.5G1502SBRGDA1DIII - DIVG1489
hNav1.5R1512WBRGDA1DIII - DIVR1499
hNav1.5I1521KBRGDA1DIII - DIVI1508
hNav1.5V1525MBRGDA1DIII - DIVV1512
hNav1.5K1527RBRGDA1DIII - DIVN1514
hNav1.5E1548KBRGDA1DIV S1-S2E1535
hNav1.5A1569PBRGDA1DIV S2I1556
hNav1.5F1571CBRGDA1DIV S2F1558
hNav1.5E1574KBRGDA1DIV S2E1561
hNav1.5L1582PBRGDA1DIV S2-S3L1569
hNav1.5R1583CBRGDA1DIV S2-S3R1570
hNav1.5R1583HBRGDA1DIV S2-S3R1570
hNav1.5V1604MBRGDA1DIV S3V1591
hNav1.5Q1613LBRGDA1DIV S3-S4E1600
hNav1.5T1620MBRGDA1DIV S3-S4T1607
hNav1.5R1623QBRGDA1DIV S4R1610
hNav1.5R1629QBRGDA1DIV S4R1616
hNav1.5G1642EBRGDA1DIV S5G1629
hNav1.5R1644CBRGDA1DIV S5R1631
hNav1.5A1649VBRGDA1DIV S5A1636
hNav1.5I1660VBRGDA1DIV S5I1647
hNav1.5G1661RBRGDA1DIV S5G1648
hNav1.5V1667IBRGDA1DIV S5V1654
hNav1.5S1672YBRGDA1DIV S5A1659
hNav1.5A1680TBRGDA1DIV S5-S6A1667
hNav1.5A1698TBRGDA1DIV S5-S6G1685
hNav1.5T1709MBRGDA1DIV S5-S6T1696
hNav1.5T1709RBRGDA1DIV S5-S6T1696
hNav1.5G1712SBRGDA1DIV S5-S6G1699
hNav1.5D1714GBRGDA1DIV S5-S6D1701
hNav1.5N1722DBRGDA1DIV S5-S6N1709
hNav1.5C1728RBRGDA1DIV S5-S6C1715
hNav1.5C1728WBRGDA1DIV S5-S6C1715
hNav1.5G1740RBRGDA1DIV S5-S6G1728
hNav1.5G1743EBRGDA1DIV S5-S6G1731
hNav1.5G1743RBRGDA1DIV S5-S6G1731
hNav1.5V1764FBRGDA1DIV S6V1752
hNav1.5T1779MBRGDA1C-terminusT1767
hNav1.5E1784KBRGDA1C-terminusE1772
hNav1.5Y1795HBRGDA1C-terminusY1783
hNav1.5Y1795YDBRGDA1C-terminusY1783
hNav1.5Q1832EBRGDA1C-terminusK1820
hNav1.5C1850SBRGDA1C-terminusC1838
hNav1.5V1861IBRGDA1C-terminusV1849
hNav1.5K1872NBRGDA1C-terminusR1860
hNav1.5V1903LBRGDA1C-terminusV1891
hNav1.5A1924TBRGDA1C-terminusI1912
hNav1.5G1935SBRGDA1C-terminusG1920
hNav1.5E1938KBRGDA1C-terminusD1923
hNav1.5V1951LBRGDA1C-terminusN1936
hNav1.5I1968SBRGDA1C-terminusT1949
hNav1.5F2004LBRGDA1C-terminusD1982
hNav1.5F2004VBRGDA1C-terminusD1982
hNav1.5T220ISSS1DI S4T215
hNav1.5A735VSSS1DII S1-S2A762
hNav1.5P1298LSSS1DIII S3-S4P1285
hNav1.5G1408RSSS1DIII S5-S6G1395
hNav1.5D1792NSSS1C-terminusE1780
hNav1.5S1710LVF1DIV S5-S6S1697
hNav1.5F532CSIDSDI - DIIF557
hNav1.5S941NSIDSDII - DIIIS970
hNav1.5G1084SSIDSDII - DIII
hNav1.5S1333YSIDSDIII S4-S5S1320
hNav1.5F1705SSIDSDIV S5-S6F1692
hNav1.5D1275NATRST1DIII S3D1262
hNav1.5D1275NCMD1EDIII S3D1262
hNav1.5M138IATFB10DI S1M133
hNav1.5E428KATFB10DI - DIIK417
hNav1.5H445DATFB10DI - DIIQ434
hNav1.5N470KATFB10DI - DIIS472
hNav1.5A572DATFB10DI - DIIS599
hNav1.5E655KATFB10DI - DIID682
hNav1.5E1053KATFB10DII - DIIIE1095
hNav1.5T1131IATFB10DII - DIIIE1140
hNav1.5R1826CATFB10C-terminusL1814
hNav1.5V1951MATFB10C-terminusN1936
hNav1.5N1987KATFB10C-terminusE1967
hNav1.5R222QMEPPCDI S4R217

PFHB1A: Progressive familial heart block 1A; LQT3: Long QT syndrome 3; BRGDA1: Brugada syndrome 1; SSS1: Sick sinus syndrome 1; VF1: Familial paroxysmal ventricular fibrillation 1; SIDS: Sudden infant death syndrome; ATRST1: Atrial standstill 1; CMD1E: Cardiomyopathy, dilated 1E; ATFB10: Atrial fibrillation, familial, 10; MEPPC: Multifocal ectopic Purkinje-related premature contraction

Table 7

Structural mapping of disease-related mutations identified in human Nav1.6

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.6D58NEIEE13N-terminusD52
hNav1.6F210LEIEE13DI S3-S4F204
hNav1.6G214DEIEE13DI S3-S4G208
hNav1.6N215REIEE13DI S3-S4N209
hNav1.6V216DEIEE13DI S3-S4V210
hNav1.6R223GEIEE13DI S4R217
hNav1.6F260SEIEE13DI S5F254
hNav1.6L407FEIEE13DI S6L398
hNav1.6V410LEIEE13DI - DIIV401
hNav1.6E479VEIEE13DI - DIIE464
hNav1.6R530WEIEE13DI - DIIH515
hNav1.6R662CEIEE13DI - DIIQ643
hNav1.6T767IEIEE13DII S1T758
hNav1.6F846SEIEE13DII S4F837
hNav1.6R850QEIEE13DII S4R841
hNav1.6L875QEIEE13DII S5L866
hNav1.6A890TEIEE13DII S5A881
hNav1.6V960DEIEE13DII S6V951
hNav1.6N984KEIEE13DII - DIIIN975
hNav1.6I1327VEIEE13DIII S4-S5I1321
hNav1.6L1331VEIEE13DIII S5L1325
hNav1.6G1451SEIEE13DIII S6G1444
hNav1.6G1451SEIEE13DIII S6G1444
hNav1.6N1466KEIEE13DIII S6N1459
hNav1.6N1466TEIEE13DIII S6N1459
hNav1.6I1479VEIEE13DIII - DIVI1472
hNav1.6E1483KEIEE13DIII - DIVE1476
hNav1.6I1583TEIEE13DIV S2-S3V1576
hNav1.6V1592LEIEE13DIV S3V1585
hNav1.6S1596CEIEE13DIV S3S1589
hNav1.6I1605REIEE13DIV S3L1598
hNav1.6R1617QEIEE13DIV S4R1610
hNav1.6L1621WEIEE13DIV S4L1614
hNav1.6A1650TEIEE13DIV S5A1643
hNav1.6P1719REIEE13DIV S5-S6P1713
hNav1.6N1768DEIEE13DIV S6N1762
hNav1.6Q1801EEIEE13C-terminusQ1795
hNav1.6E1870DEIEE13C-terminusE1864
hNav1.6R1872WEIEE13C-terminusR1866
hNav1.6R1872QEIEE13C-terminusR1866
hNav1.6R1872LEIEE13C-terminusR1866
hNav1.6N1877SEIEE13C-terminusN1871

EIEE13: Epileptic encephalopathy, early infantile, 13

Table 8

Structural mapping of disease-related mutations identified in human Nav1.8

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.8L554PSFNDI - DII
hNav1.8M650KSFNDI - DIIY729
hNav1.8A1304TSFNDIII S5A1344
hNav1.8G1662SSFNDIV S5-S6G1699
hNav1.8I1706VSFNDIV S6I1744

SFN: Small fiber neuropathy

Table 9

Structural mapping of disease-related mutations identified in human Nav1.9

Related proteinsMutationsDiseasesStructural positionMap on hNav1.7
hNav1.9R222HFEPS3DI S4R214
hNav1.9R222SFEPS3DI S4R214
hNav1.9R225CFEPS3DI S4R217
hNav1.9I381TFEPS3DI S6V383
hNav1.9G699RFEPS3DII S5G864
hNav1.9A808GFEPS3DII S6A965
hNav1.9L811PHSAN7DII S6L968
hNav1.9L1158PFEPS3DIII S4L1301
hNav1.9V1184AHSAN7DIII S5V1327

FEPS3: Episodic pain syndrome, familial, 3; HSAN7: Neuropathy, hereditary sensory and autonomic, 7

Table 10

Summary of sodium channelopathies

Related proteinsDiseases
hNav1.1 GEFS+2: Generalized epilepsy with febrile seizures plus 2
EIEE6: Epileptic encephalopathy, early infantile, 6
ICEGTC: Intractable childhood epilepsy with generalized tonic-clonic seizures
FHM3: Migraine, familial hemiplegic, 3
FEB3A: Febrile seizures, familial, 3A
hNav1.2 BFIS3: Seizures, benign familial infantile 3
EIEE11: Epileptic encephalopathy, early infantile, 11
DS: Dravet syndrome
hNav1.3 CPE: Cryptogenic partial epilepsy
hNav1.4 PMC: Paramyotonia congenita of von Eulenburg
HOKPP2: Periodic paralysis hypokalemic 2
HYPP: Periodic paralysis hyperkalemic
NKPP: Periodic paralysis normokalemic
MYOSCN4A: Myotonia SCN4A-related
CMS16: Myasthenic syndrome, congenital, 16
hNav1.5 PFHB1A: Progressive familial heart block 1A
LQT3: Long QT syndrome 3
BRGDA1: Brugada syndrome 1
SSS1: Sick sinus syndrome 1
VF1: Familial paroxysmal ventricular fibrillation 1
SIDS: Sudden infant death syndrome
ATRST1: Atrial standstill 1
CMD1E: Cardiomyopathy, dilated 1E
ATFB10: Atrial fibrillation, familial, 10
MEPPC: Multifocal ectopic Purkinje-related premature contraction
hNav1.6 EIEE13: Epileptic encephalopathy, early infantile, 13
hNav1.7 IEM: Primary erythermalgia
PEPD: Paroxysmal extreme pain disorder
CIP: Indifference to pain, congenital, autosomal recessive
DS: Dravet syndrome
SFN: Small fiber neuropathy
FEB: Febrile eizures
hNav1.8 SFN: Small fiber neuropathy
hNav1.9 FEPS3: Episodic pain syndrome, familial, 3
HSAN7: Neuropathy, hereditary sensory and autonomic, 7
Structural mapping of disease-related mutations identified in human Nav1.7 IEM: Primary erythermalgia; PEPD: Paroxysmal extreme pain disorder; CIP: Indifference to pain, congenital, autosomal recessive; DS: Dravet syndrome; SFN: Small fiber neuropathy; FEB: Febrile seizures Structural mapping of disease-related mutations identified in human Nav1.1 GEFS+2: Generalized epilepsy with febrile seizures plus 2; EIEE6: Epileptic encephalopathy, early infantile, 6; ICEGTC: Intractable childhood epilepsy with generalized tonic-clonic seizures; FHM3: Migraine, familial hemiplegic, 3; FEB3A: Febrile seizures, familial, 3A Structural mapping of disease-related mutations identified in human Nav1.2 BFIS3: Seizures, benign familial infantile 3; EIEE11: Epileptic encephalopathy, early infantile, 11; DS: Dravet syndrome Structural mapping of disease-related mutations identified in human Nav1.3 CPE: Cryptogenic partial epilepsy Structural mapping of disease-related mutations identified in human Nav1.4 PMC: Paramyotonia congenita of von Eulenburg; HOKPP2: Periodic paralysis hypokalemic 2; HYPP: Periodic paralysis hyperkalemic; NKPP: Periodic paralysis normokalemic; MYOSCN4A: Myotonia SCN4A-related; CMS16: Myasthenic syndrome, congenital, 16 Structural mapping of disease-related mutations identified in human Nav1.5 PFHB1A: Progressive familial heart block 1A; LQT3: Long QT syndrome 3; BRGDA1: Brugada syndrome 1; SSS1: Sick sinus syndrome 1; VF1: Familial paroxysmal ventricular fibrillation 1; SIDS: Sudden infant death syndrome; ATRST1: Atrial standstill 1; CMD1E: Cardiomyopathy, dilated 1E; ATFB10: Atrial fibrillation, familial, 10; MEPPC: Multifocal ectopic Purkinje-related premature contraction Structural mapping of disease-related mutations identified in human Nav1.6 EIEE13: Epileptic encephalopathy, early infantile, 13 Structural mapping of disease-related mutations identified in human Nav1.8 SFN: Small fiber neuropathy Structural mapping of disease-related mutations identified in human Nav1.9 FEPS3: Episodic pain syndrome, familial, 3; HSAN7: Neuropathy, hereditary sensory and autonomic, 7 Summary of sodium channelopathies Despite significant advancement in the understanding of Nav channel functions and their relevance to diseases, structural characterization of mammalian Nav channels at atomic level has been challenging, partly due to the substantial technical hurdles in producing mammalian Nav channel proteins in sufficient amount with acceptable purity. The two published bacterial Nav channel crystal structures, NavAb (Payandeh et al., 2011) and NavRh (Zhang et al., 2012), in their full-length have greatly improved our understanding of how those channels conduct and select sodium ions on a structural basis. This is further enhanced by the recently published cryo-electron microscopy (cryo-EM) structure of the rabbit voltage-gated calcium (Cav) channel Cav1.1 (Wu et al., 2015; Wu et al., 2016), which, given the significant similarities between Cav and Nav channels, provides an excellent base model for studying the structure and function of the mammalian Nav channels in lieu of the elusive Nav channel structure (Wu et al., 2015; Wu et al., 2016). In this Resource article, we have built a structure model of the human sodium channel Nav1.7 based on the Cav1.1 cryo-EM structure (PDB code: 5GJV). Disease-related mutations of various Nav channels are systematically mapped onto this Nav1.7 structural model. As expected, most mutations are located in the VSDs and the pore domain, which corroborate the functional disturbance associated with the various conditions. The human Nav1.7 structure model may also provide a useful tool for the structure-based design of drugs that are able to therapeutically target the Nav channels.

STRUCTURE MODEL OF HUMAN SODIUM CHANNEL Nav1.7

Homology models of the mammalian Nav channels have been previously constructed based on the crystal structures of the eukaryotic potassium channels or the prokaryotic sodium channels (Tikhonov and Zhorov, 2012; Yang et al., 2012). However, the relevance of such models has been in question, since the eukaryotic sodium channels are known to be heterotetrameric while the prokaryotic sodium channels and the potassium channels are of homotetrameric nature. We sought to build a homology-based structural model for human Nav1.7 because of the tremendous interest in drug development targeting this channel. The sequence identity and similarity between human Nav1.7 and rabbit Cav1.1 are 21 and 35%, respectively (Please refer to the online Supplementary Fig. 2 of Wu et al., 2016). Importantly, the key amino acids within the VSDs and the pore domains are highly conserved (Wu et al., 2015; Wu et al., 2016). The cryo-EM structure of rabbit Cav1.1 was then used as the template for homology modeling of human Nav1.7. The primary sequence of human Nav1.7 was aligned with rabbit Cav1.1 in MOE with manual adjustment when necessary. The structure model of human Nav1.7 was created with the Homology Model module in MOE using the GB/VI scoring function with AMBER12:EHT force field (MOE, 2016). The human Nav1.7 model structure resembles the structure of rCav1.1 in general (Fig. 1A). However, the model exhibits pronounced differences from the calcium channel and bacterial sodium channels particularly in selectivity filter. The SF of Nav1.7 consists of four different amino acid residues DEKA (Fig. 1B). In contrast, the Cav1.1 SF is constituted by four repeated essential glutamic acids, EEEE, while NavAb and NavRh contain TLESWS or TLSSWE in each protomer, respectively. This human Nav1.7 structure model represents the first one-chain sodium channel model with asymmetric repeats and is expected to shed new light on the mammalian sodium channel functions.
Figure 1

Homology model structure of human Nav1.7 sodium channel. (A) Intra-membrane view and extracellular view of the structure model of Nav1.7. The four domains are colored green, light blue, cyan, and gray for domain I, II, III, and IV, respectively. (B) The pore domain of Nav1.7 structure model. The S5–S6 segments of Nav1.7 are shown and the four selectivity filter amino acids are shown as sticks (left). A close-up view of the four SF residues, D361 in domain I, E927 in domain II, K1406 in domain III, and A1698 in domain IV (right)

Homology model structure of human Nav1.7 sodium channel. (A) Intra-membrane view and extracellular view of the structure model of Nav1.7. The four domains are colored green, light blue, cyan, and gray for domain I, II, III, and IV, respectively. (B) The pore domain of Nav1.7 structure model. The S5–S6 segments of Nav1.7 are shown and the four selectivity filter amino acids are shown as sticks (left). A close-up view of the four SF residues, D361 in domain I, E927 in domain II, K1406 in domain III, and A1698 in domain IV (right)

MAPPING OF DISEASE-RELEVANT MUTATIONS ONTO THE Nav1.7 STRUCTURE MODEL

Human Nav1.7 sodium channel is preferentially expressed in the sensory neurons of dorsal root ganglia and sympathetic ganglia neurons, particularly within the nociceptors, which is essential for perceiving pain (Djouhri et al., 2003; Dib-Hajj et al., 2013). To date, about 60 mutations of Nav1.7 have been found to cause human pain syndromes including IEM, PEPD, CIP, SFN (small fiber neuropathy), DS (Dravet syndrome), and FEB (febrile seizure) (Fig. 2 and Table 1). We mapped all the reported Nav1.7 mutations onto this Nav1.7 structure model (Fig. 2). Nineteen out of 22 IEM mutations are located in the highly conserved regions of VSDs and the pore domain except for the Q10R, P610T, and G616R mutations (Fig. 2). Electrophysiology study showed that IEM mutations cause a prominent shift of the activation voltage toward a more negative region or delay deactivation, which results in neuron hyperexcitability (Choi et al., 2006; Lampert et al., 2006; Choi et al., 2009; Lampert et al., 2010). For example, mutation of A1643 within the S5 segment of domain IV to glycine (A1643G) generates a significant hyperpolarizing shift (Yang et al., 2016). Our structural analysis shows that only two IEM mutations F216S and L834R are located in the S4 positively charged segment that is directly responsible for transmembrane voltage sensing and channel activation. How other IEM mutations influence voltage sensing and channel functions is yet to be elucidated.
Figure 2

Amino acid locations of Nav1.7 disease-related mutations on the Nav1.7 structure model. (A) The topology of human Nav1.7 sodium channel. Cylinders represent the transmembrane segments, which are colored in gray except that the S4 voltage-sensing segments are colored in yellow. The lines represent the soluble regions between the transmembrane segments or the N/C-terminus. The two P helices between S5 and S6 segments are shown in cylinders. Mutations of Nav1.7 are discriminately mapped on the topology scheme of Nav1.7 by different colors, namely, IEM (blue), PEPD (red), CIP (cyan), DS (purple), SFN (green), and FEB (pink). (B) Intra-membrane view and intracellular views of the Nav1.7 structure model. Mapping of disease-related mutations onto the Nav1.7 structure model is highlighted by different colors. Summary of Nav1.7 mutations is shown in different gray boxes

Amino acid locations of Nav1.7 disease-related mutations on the Nav1.7 structure model. (A) The topology of human Nav1.7 sodium channel. Cylinders represent the transmembrane segments, which are colored in gray except that the S4 voltage-sensing segments are colored in yellow. The lines represent the soluble regions between the transmembrane segments or the N/C-terminus. The two P helices between S5 and S6 segments are shown in cylinders. Mutations of Nav1.7 are discriminately mapped on the topology scheme of Nav1.7 by different colors, namely, IEM (blue), PEPD (red), CIP (cyan), DS (purple), SFN (green), and FEB (pink). (B) Intra-membrane view and intracellular views of the Nav1.7 structure model. Mapping of disease-related mutations onto the Nav1.7 structure model is highlighted by different colors. Summary of Nav1.7 mutations is shown in different gray boxes The PEPD mutations are mostly characterized (nine out of 11) within the S4 segment, S4-S5 linker region, and the cytosolic regions of domain III and domain IV of Nav1.7 except for R185H and R1007C (Fig. 2A and Table 1). Specifically, I1472T, F1473V, and T1475I are within the IFMT motif (Fig. 2A), indicating that they may disturb channel inactivation. Indeed, IFMT mutations usually impair fast inactivation with consequently persistent currents (Fertleman et al., 2006). The V1309D, V1309F, and V1310F mutations are located in the S4-S5 linker region of domain III and they have been shown to cause moderate destabilization of fast inactivation (Jarecki et al., 2008). The G1618R mutation, located within the S4 segment of domain IV, impairs inactivation and retains a persistent current compared to the wild-type (WT) channel (Choi et al., 2011), while another domain IV S4 segment mutation, L1623P, significantly increases ramp current and shortens recovery time from inactivation (Suter et al., 2015). Moreover, electrophysiology study showed that M1638K mutation (within the S5 segment of domain IV) generates faster recovery from inactivation than the WT channel, producing greater currents and reducing the threshold with increased number of action potentials (Fertleman et al., 2006; Dib-Hajj et al., 2008). Another PEPD mutation, A1643E, also located in the S5 segment of domain IV, impedes channel full inactivation, which results in persistent inward currents (Estacion et al., 2008). The CIP patients, characterized by lack of nociceptive perception, are mostly inflicted by Nav1.7 nonsense mutations, which result in premature protein truncations and inability to produce functional sodium channels. Only three mutations of Nav1.7, namely R907Q, A1247E, and W1786R, have been reported to be associated with CIP (Fig. 2 and Table 1). Diseases such as DS, SFN, and FEB are also known to be caused by Nav1.7 mutations (Fig. 2 and Table 1). For example, all eight SFN mutations have been characterized. Specifically, I228M, I731K, I750V, and M1543I mutations impair slow inactivation, D623N impedes slow and fast inactivation, while R185H, M943L, and V1002L mutations enhance resurgent currents (Faber et al., 2012a). On the other hand, Nav1.7 mutations that are associated with DS (nine mutations) and FEB (six mutations) have not been well characterized.

MAPPING OF OTHER HUMAN SODIUM CHANNEL DISEASE-RELATED MUTATIONS ONTO THE Nav1.7 STRUCTURE MODEL

Members of the human Nav channel family share high sequence similarity and mutations of these Nav channels are known to cause a vast variety of channelopathies. In order to better understand the role of those mutations in disturbing normal channel functions on a structural level, we mapped the disease-related mutations of other human Nav channels onto the Nav1.7 structure model based on the sequence alignment reported in Wu et al., 2016 (Fig. 3).
Figure 3

Mapping of Nav channel disease-related mutations onto the Nav1.7 structure model. The Nav1.7 channel is shown in cartoon from the intra-membrane view. The Cα atoms of the disease-related amino acids are shown in spheres. Mapped mutations from nine Nav sodium channels to the Nav1.7 structure model are differentiated by distinct colors, Nav1.1 (A, blue), Nav1.2 (B, cyan), Nav1.3 (C, magenta), Nav1.4 (D, purple blue), Nav1.5 (E, pale cyan), Nav1.6 (F, orange), Nav1.7 (G, red), Nav1.8 (H, green), and Nav1.9 (I, salmon)

Mapping of Nav channel disease-related mutations onto the Nav1.7 structure model. The Nav1.7 channel is shown in cartoon from the intra-membrane view. The Cα atoms of the disease-related amino acids are shown in spheres. Mapped mutations from nine Nav sodium channels to the Nav1.7 structure model are differentiated by distinct colors, Nav1.1 (A, blue), Nav1.2 (B, cyan), Nav1.3 (C, magenta), Nav1.4 (D, purple blue), Nav1.5 (E, pale cyan), Nav1.6 (F, orange), Nav1.7 (G, red), Nav1.8 (H, green), and Nav1.9 (I, salmon) Among all the nine Nav channels, Nav1.1 and Nav1.5 have the largest numbers of reported mutations (more than 400 each) (Fig. 3A and 3E), while Nav1.3, Nav1.8, and Nav1.9 have the least numbers (less than 10 each) (Fig. 3C, 3H, and 3I). Notably, mutations in Nav1.1, Nav1.2, Nav1.3, and Nav1.6 mainly cause epilepsies; those in Nav1.4 are related to myopathies; in Nav1.5 result in cardiac channelopathies; and in Nav1.7, Nav1.8, and Nav1.9 are associated with pain-related diseases (Fig. 3 and Tables 1, 2, 3, 4, 5, 6, 7, 8, 9, 10). Mapping of all Nav channel mutations onto the Nav1.7 structure model revealed that more than 80% of mutations are located in the VSDs and pore domains (Fig. 4A and 4B). Notably, disease-causing mutations are somewhat equally distributed in all four Nav channel domains, which account for more than 20 sodium channelopathies (Fig. 4C). Furthermore, mutations are also distributed in various regions of the pore domains, suggesting that they may disturb Nav channel functions by altering sodium ion selectivity and conductivity (Fig. 4D).
Figure 4

Mutations that cause sodium channelopathies are plotted on the Nav1.7 sodium channel model. (A) The amino acid residues related with sodium channelopathies are mapped on the Nav1.7 structure model. All mutated residues are shown in spheres and colored for Nav1.1 (blue), Nav1.2 (cyan), Nav1.3 (magenta), Nav1.4 (purple blue), Nav1.5 (pale cyan), Nav1.6 (orange), Nav1.7 (red), Nav1.8 (green), and Nav1.9 (salmon). (B) The distribution of sodium channelopathy-related mutations on the transmembrane regions of the Nav1.7 structure model. Mutations of the VSDs and the pore domain are shown from the intra-membrane and intracellular views. (C) The mutation distributions for the four domains. S1–S6 segments are shown in cylindrical helices. (D) Mapping mutations to the pore domain in four different views

Mutations that cause sodium channelopathies are plotted on the Nav1.7 sodium channel model. (A) The amino acid residues related with sodium channelopathies are mapped on the Nav1.7 structure model. All mutated residues are shown in spheres and colored for Nav1.1 (blue), Nav1.2 (cyan), Nav1.3 (magenta), Nav1.4 (purple blue), Nav1.5 (pale cyan), Nav1.6 (orange), Nav1.7 (red), Nav1.8 (green), and Nav1.9 (salmon). (B) The distribution of sodium channelopathy-related mutations on the transmembrane regions of the Nav1.7 structure model. Mutations of the VSDs and the pore domain are shown from the intra-membrane and intracellular views. (C) The mutation distributions for the four domains. S1–S6 segments are shown in cylindrical helices. (D) Mapping mutations to the pore domain in four different views Nav1.2 mutations are largely associated with various epilepsy diseases, including BFIS3 (seizures, benign familial infantile 3), EIEE11 (epileptic encephalopathy, early infantile, 11), and DS (Fig. 3B and Table 3). More than 30 Nav1.2 mutations have been discovered and some of them are now functionally characterized. Interestingly, electrophysiological studies showed that Nav1.2 mutations can either be loss-of-function (R1319Q and L1330F) or gain-of-function (M252V, V261M, L1563V, and Y1579C) (Misra et al., 2008; Liao et al., 2010; Lauxmann et al., 2013). It is noted that BFIS3 mutations in Nav1.2 create less pronounced changes in the activation and inactivation potentials than the EIEE11 mutations (Shi et al., 2012). Only six missense mutations of Nav1.3 have so far been identified in patients with cryptogenic partial epilepsy (Fig. 3C and Table 4). Five of them, namely K354Q, R357Q, D815N, E1160K, and M1372V, have been characterized, all of which are gain-of-function mutations, consistent with the neuronal hyperexcitability phenotype (Estacion et al., 2010; Vanoye et al., 2014). Nav1.4 is essential for controlling the muscle action potential and consequently crucial for skeletal muscle contraction. Mutations of Nav1.4 are related with various neuromuscular disorders including PMC (paramyotonia congenita of von Eulenburg), HOKPP2 (periodic paralysis hypokalemic 2), HYPP (periodic paralysis hyperkalemic), NKPP (periodic paralysis normokalemic), MYOSCN4A (myotonia SCN4A-related), and CMS16 (myasthenic syndrome, congenital, 16) (Fig. 3D and Table 5). Different disease-causing mutations alter the Nav1.4 channel function through distinct mechanisms. For example, CMS16 mutations R104H, P382T, and C1209F completely abolish the Nav1.4 channel’s ability to conduct sodium ion, while other mutations such as M203K, R225W, and D1069N cause reduced action potential amplitude, leading to impaired channel function (Zaharieva et al., 2016). Compared to the WT channel, a CMS16 voltage sensor mutant R1457H requires longer hyperpolarization to recover which results in increased fast inactivation (Arnold et al., 2015). On the other hand, a HOKPP2 mutation R1135H (the third arginine in the domain III voltage sensor) exhibits increased depolarization, suggesting that R1135H mutation be gain-of-function (Groome et al., 2014). A MYOSCN4A mutation I582V shows a hyperpolarizing shift of 6 mV, indicating the nature of this mutation be also gain-of-function (Corrochano et al., 2014). Nav1.6 is one of the sodium channels expressed in human brain and mutations of Nav1.6 cause EIEE13 (epileptic encephalopathy, early infantile, 13) (Fig. 3F and Table 7). More than 40 Nav1.6 mutations have been discovered since 2012 (Fig. 3F and Table 7), and seven of them have been studied in the functional assays. Specifically, five Nav1.6 mutations, namely T767I, N984K, T1716I, N1768D, and R1872W/R1872Q/R1872L, are characterized as gain-of-function, which cause hyperpolarizing shift of inactivation voltage or increased persistent current (Veeramah et al., 2012; Estacion et al., 2014; Wagnon et al., 2016), while the other two mutations, R223G and G1451S, are loss-of-function (de Kovel et al., 2014; Blanchard et al., 2015). Five Nav1.8 mutations are associated with SFN, a condition that is clinically characterized by autonomic dysfunction and burning pain in the distal extremities (Fig. 3H and Table 8). Electrophysiology study has shown that Nav1.8 mutations, specifically L554P, A1304T, G1662S, and I1706V, accelerate inactivation recovery and enhance activation, which result in hyperexcitability (Faber et al., 2012b; Huang et al., 2013; Han et al., 2014). However, another SFN Nav1.8 mutation M650K causes reduced excitability of C fibers (Kist et al., 2016). FEPS3 (episodic pain syndrome, familial, 3) and HSAN7 (neuropathy, hereditary sensory and autonomic, 7) are thought to be caused by the nine missense gain-of-function mutations of Nav1.9 (Fig. 3I and Table 9). Specifically, compared to the WT channel, R225C and A808G mutations induce hyperexcitability of the DRG neurons (Zhang et al., 2013), G699R enhances activation (Han et al., 2015), L811P significantly increases current density (Leipold et al., 2013), L1158P enhances spontaneous firing (Huang et al., 2014), and V1184A alters the channel voltage dependence that results in channel opening in response to hyperpolarized potentials (Leipold et al., 2015).

DISEASE-RELATED MUTATIONS IN SODIUM CHANNELS Nav1.1 AND Nav1.5

Mutations of Nav1.1 are associated with several neurological disorders including GEFS+2, EIEE6, ICEGTC, FHM3 (migraine, familial hemiplegic, 3), and FEB3A (febrile seizures, familial, 3A) (Table 2 and Table 10). More than 400 mutations of Nav1.1 have been identified, approximately 10% account for GEFS+2 while 80% for EIEE6 (Fig. 5A and Table 2). By mapping the Nav1.1-related mutations to the Nav1.7 structure model, we identified that most mutations are located in the VSDs and the pore domain (Fig. 5A). For example, mutations of the four positively charged residues, R1639G, R1642S, R1645Q, and R1648C, are present in the domain IV S4 segment (Table 2), suggesting that these EIEE6 mutations may alter the voltage sensing behavior of the channel. In addition, it is noteworthy that Nav1.1 mutations can be either loss-of-function or gain-of-function (Catterall et al., 2010; Escayg and Goldin, 2010). For example, two GEFS+2 mutations W1204R and R1648H increase the level of persistent current through gain-of-function (Lossin et al., 2002), while the loss-of-function M145T mutation in FEB3A decreases 60% of the current density (Mantegazza et al., 2005).
Figure 5

Distributions of the missense mutations in Nav1.1 and Nav1.5. (A) Distributions of Nav1.1 missense mutations on the Nav1.7 model structure. More than 400 mutations are mapped. Mutations from five Nav1.1-related diseases are shown from intra-membrane, intracellular, and extracellular views. The Nav1.7 model is shown in cylindrical helices and colored by GEFS+2 in red, EIEE6 in blue, ICEGTC in cyan, FHM3 in green, and FEB3A in yellow. (B) Distributions of Nav1.5 related-disease mutations on the Nav1.7 structure model. Mutations from Nav1.5 related diseases are shown from intra-membrane, intracellular, and extracellular views. Different diseases are colored in green for PFHB1A, blue for LQT3, red for BRGDA1, cyan for SSS1, and magenta for VF1, SIDS, ATRST1, CMD1E, ATFB10, and MEPPC

Distributions of the missense mutations in Nav1.1 and Nav1.5. (A) Distributions of Nav1.1 missense mutations on the Nav1.7 model structure. More than 400 mutations are mapped. Mutations from five Nav1.1-related diseases are shown from intra-membrane, intracellular, and extracellular views. The Nav1.7 model is shown in cylindrical helices and colored by GEFS+2 in red, EIEE6 in blue, ICEGTC in cyan, FHM3 in green, and FEB3A in yellow. (B) Distributions of Nav1.5 related-disease mutations on the Nav1.7 structure model. Mutations from Nav1.5 related diseases are shown from intra-membrane, intracellular, and extracellular views. Different diseases are colored in green for PFHB1A, blue for LQT3, red for BRGDA1, cyan for SSS1, and magenta for VF1, SIDS, ATRST1, CMD1E, ATFB10, and MEPPC Nav1.5 is the primary sodium channel in the heart and is essential for the cardiac action potential initiation. More than 400 Nav1.5 mutations have been discovered and they are implicated in a wide variety of cardiac diseases—including PFHB1A (progressive familial heart block 1A), LQT3, BRGDA1, SSS1, VF1 (familial paroxysmal ventricular fibrillation 1), SIDS (sudden infant death syndrome), ATRST1 (atrial standstill 1), CMD1E (cardiomyopathy, dilated 1E), ATFB10 (atrial fibrillation, familial, 10), and MEPPC (multifocal ectopic Purkinje-related premature contractions) (Fig. 5B and Table 6). By mapping all the Nav1.5 mutations onto the Nav1.7 structure model, it shows that most mutations are located in the transmembrane regions of the channel, suggesting that these mutations might disturb voltage sensing or sodium conduction (Fig. 5B). Furthermore, about 50% of the Nav1.5 mutations account for BRGDA1, while 30% for LQT3. Similar to the case of Nav1.1, mutations in Nav1.5 can be either loss-of-function or gain-of-function. For example, loss-of-function mutations are associated with BRGDA1, CMD1E, SSS1, and ATFB10 (Tan et al., 2001; Smits et al., 2005; Makiyama et al., 2008; Laurent et al., 2012), while gain-of-function mutations of Nav1.5 are responsible for LQT3 (Remme et al., 2006), CMD1E, and ATFB10 (Olson et al., 2005), and most recently MEPPC (Swan et al., 2014).

CONCLUDING REMARKS

The Nav family of sodium channels are important drug targets for the pharmaceutical industry. However, no atomic structure of any mammalian Nav channels is currently available, preventing the establishment of an in-depth structure-function relationship for this important group of sodium channels and application of structure-based approach to rationally design compounds that are able to modulate the functions of those Nav channels in a disease relevant manner. Using the recently published cryo-EM structure of a rabbit Cav channel Cav1.1, we established an atomic level heterotetrameric structure model for the human Nav channel Nav1.7. Disease-related mutations of Nav1.7 and other members of the Nav family, which are largely responsible for many neurological disorders like epilepsies, pains, and myopathies, are mapped onto the structure model. Taken together the available functional data, we attempted to establish a rudimentary structure-function relationship for human Nav1.7 and other members of the Nav channel family. It is noticeable that sodium channelopathies can be attributed to both loss-of-function and gain-of-function mutations. However, we must realize that the current Nav1.7 structural model has its limitation and the atomic resolution mammalian Nav channel structure is urgently needed. In recent years, cryo-EM technology is becoming a mainstream technology for structural biology, which is able to potentially overcome the significant technical hurdles in producing challenging proteins such as mammalian Nav channels in sufficient quality and the necessity of crystallization for structural elucidation. Detailed mechanisms of how the Nav channels sense voltage changes and conduct sodium ions can only be answered when such atomic resolution structures become available. We hope the Nav1.7 structure model presented here is a temporary surrogate to help understand the Nav channel functions, particularly those relevant to the various neurological diseases, at atomic level, and contributes to the structure-based rational design of the next generation Nav channel modulators.

SUMMARY OF DISEASE-RELATED MUTATIONS FOR SODIUM CHANNELS

Most of the Nav channel disease-related mutations are extracted from the UNIPROT websites: http://www.uniprot.org/uniprot/P35498 (Nav1.1); http://www.uniprot.org/uniprot/Q99250 (Nav1.2); http://www.uniprot.org/uniprot/P35499 (Nav1.4); http://www.uniprot.org/uniprot/Q14524 (Nav1.5); http://www.uniprot.org/uniprot/Q9UQD0 (Nav1.6); http://www.uniprot.org/uniprot/Q15858 (Nav1.7); http://www.uniprot.org/uniprot/Q9Y5Y9 (Nav1.8); http://www.uniprot.org/uniprot/Q9UI33 (Nav1.9). In the UNIPROT websites, there are no mutations described for Nav1.3. During literatures searching, we found that six mutations of Nav1.3 are associated with cryptogenic partial epilepsy. Except for the present mutations in the UNIPROT websites, we found additional mutations of Nav channels in literatures. All mutations are summarized in Tables 1, 2, 3, 4, 5, 6, 7, 8, 9. However, we recognize that our summary may not contain all Nav channel disease-related mutations owing to abundant literatures reporting Nav channel disease-related mutations and increasing volume of work describing new findings. Below is the link to the electronic supplementary material. Supplementary material 1 (PDB 2287 kb)
  70 in total

1.  Mechanism of ion permeation and selectivity in a voltage gated sodium channel.

Authors:  Ben Corry; Michael Thomas
Journal:  J Am Chem Soc       Date:  2012-01-12       Impact factor: 15.419

2.  Structure of the voltage-gated calcium channel Cav1.1 complex.

Authors:  Jianping Wu; Zhen Yan; Zhangqiang Li; Chuangye Yan; Shan Lu; Mengqiu Dong; Nieng Yan
Journal:  Science       Date:  2015-12-18       Impact factor: 47.728

Review 3.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

4.  Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6 Å resolution.

Authors:  Jianping Wu; Zhen Yan; Zhangqiang Li; Xingyang Qian; Shan Lu; Mengqiu Dong; Qiang Zhou; Nieng Yan
Journal:  Nature       Date:  2016-08-31       Impact factor: 49.962

5.  A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.

Authors:  Jeroen P P Smits; Tamara T Koopmann; Ronald Wilders; Marieke W Veldkamp; Tobias Opthof; Zahir A Bhuiyan; Marcel M A M Mannens; Jeffrey R Balser; Hanno L Tan; Connie R Bezzina; Arthur A M Wilde
Journal:  J Mol Cell Cardiol       Date:  2005-04-01       Impact factor: 5.000

6.  Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.

Authors:  Heikki Swan; Mohamed Yassine Amarouch; Jaakko Leinonen; Annukka Marjamaa; Jan P Kucera; Päivi J Laitinen-Forsblom; Annukka M Lahtinen; Aarno Palotie; Kimmo Kontula; Lauri Toivonen; Hugues Abriel; Elisabeth Widen
Journal:  Circ Cardiovasc Genet       Date:  2014-09-10

7.  Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.

Authors:  Jianying Huang; Yang Yang; Peng Zhao; Monique M Gerrits; Janneke G J Hoeijmakers; Kim Bekelaar; Ingemar S J Merkies; Catharina G Faber; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167

Review 8.  Sodium channelopathies and pain.

Authors:  Angelika Lampert; Andrias O O'Reilly; Peter Reeh; Andreas Leffler
Journal:  Pflugers Arch       Date:  2010-01-26       Impact factor: 3.657

9.  Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures.

Authors:  Massimo Mantegazza; Antonio Gambardella; Raffaella Rusconi; Emanuele Schiavon; Ferdinanda Annesi; Rita Restano Cassulini; Angelo Labate; Sara Carrideo; Rosanna Chifari; Maria Paola Canevini; Raffaele Canger; Silvana Franceschetti; Grazia Annesi; Enzo Wanke; Aldo Quattrone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

10.  Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.

Authors:  Sulayman D Dib-Hajj; Mark Estacion; Brian W Jarecki; Lynda Tyrrell; Tanya Z Fischer; Mark Lawden; Theodore R Cummins; Stephen G Waxman
Journal:  Mol Pain       Date:  2008-09-19       Impact factor: 3.395

View more
  37 in total

1.  Fenestrations control resting-state block of a voltage-gated sodium channel.

Authors:  Tamer M Gamal El-Din; Michael J Lenaeus; Ning Zheng; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-05       Impact factor: 11.205

Review 2.  Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?

Authors:  Zhi-Mei Li; Li-Xia Chen; Hua Li
Journal:  Curr Med Sci       Date:  2019-12-16

Review 3.  Sodium Channelopathies of Skeletal Muscle.

Authors:  Stephen C Cannon
Journal:  Handb Exp Pharmacol       Date:  2018

Review 4.  Structural Advances in Voltage-Gated Sodium Channels.

Authors:  Daohua Jiang; Jiangtao Zhang; Zhanyi Xia
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

5.  Backbone resonance assignments of complexes of apo human calmodulin bound to IQ motif peptides of voltage-dependent sodium channels NaV1.1, NaV1.4 and NaV1.7.

Authors:  Holly M Isbell; Adina M Kilpatrick; Zesen Lin; Ryan Mahling; Madeline A Shea
Journal:  Biomol NMR Assign       Date:  2018-05-04       Impact factor: 0.746

6.  Drosophila Voltage-Gated Sodium Channels Are Only Expressed in Active Neurons and Are Localized to Distal Axonal Initial Segment-like Domains.

Authors:  Thomas A Ravenscroft; Jasper Janssens; Pei-Tseng Lee; Burak Tepe; Paul C Marcogliese; Samira Makhzami; Todd C Holmes; Stein Aerts; Hugo J Bellen
Journal:  J Neurosci       Date:  2020-09-14       Impact factor: 6.167

7.  Employing NaChBac for cryo-EM analysis of toxin action on voltage-gated Na+ channels in nanodisc.

Authors:  Shuai Gao; William C Valinsky; Nguyen Cam On; Patrick R Houlihan; Qian Qu; Lei Liu; Xiaojing Pan; David E Clapham; Nieng Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

Review 8.  µ-Conotoxins Modulating Sodium Currents in Pain Perception and Transmission: A Therapeutic Potential.

Authors:  Elisabetta Tosti; Raffaele Boni; Alessandra Gallo
Journal:  Mar Drugs       Date:  2017-09-22       Impact factor: 5.118

9.  Chemometric Models of Differential Amino Acids at the Navα and Navβ Interface of Mammalian Sodium Channel Isoforms.

Authors:  Fernando Villa-Diaz; Susana Lopez-Nunez; Jordan E Ruiz-Castelan; Eduardo Marcos Salinas-Stefanon; Thomas Scior
Journal:  Molecules       Date:  2020-08-03       Impact factor: 4.411

10.  Regulation and drug modulation of a voltage-gated sodium channel: Pivotal role of the S4-S5 linker in activation and slow inactivation.

Authors:  Jinglei Xiao; Vasyl Bondarenko; Yali Wang; Antonio Suma; Marta Wells; Qiang Chen; Tommy Tillman; Yan Luo; Buwei Yu; William P Dailey; Roderic Eckenhoff; Pei Tang; Vincenzo Carnevale; Michael L Klein; Yan Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.